No definition available.
Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)
C3_PROSTATE_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
4 out of 7 registries used, show all original rules. |
20966 |
4. Check minimum number of eventsNone |
20966 |
5. Include endpointsNone |
20966 |
6. Filter based on genotype QC (FinnGen only) |
20966 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 20966 | - | 20966 |
| Unadjusted period prevalence (%) | 9.24 | - | 9.24 |
| Median age at first event (years) | 69.21 | - | 69.21 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3955
- Matched controls
- 32975
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L02BB03
ATC
bicalutamide; oral
+∞
323.0
444
*
L02BX02
ATC
degarelix; parenteral
+∞
323.0
342
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
26.4
323.0
1553
787
XX3DW
NOMESCO Finland
Time consuming IT work
16.3
323.0
1064
726
ZXC96
NOMESCO Finland
Robot assisted procedure
295.5
323.0
1083
42
C61
ICD-10 Finland
Malignant neoplasm of prostate
4503599627370496.0
323.0
3891
11
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
10.5
323.0
1910
2697
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
323.0
420
*
Y77
ICPC
Malignant neoplasm prostate
3474.1
323.0
709
*
TKE00
NOMESCO Finland
Needle biopsy of prostate
17.7
323.0
566
308
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
25.4
323.0
698
276
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
79.7
323.0
2276
551
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
149.0
323.0
619
41
WF002
NOMESCO Finland
Radical radiotherapy
841.5
323.0
1099
15
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
323.0
1678
*
XKD00
NOMESCO Finland
Uroflowmetry
12.2
323.0
2312
3406
NK6AN
NOMESCO Finland
Total body bone isotope imaging
357.1
323.0
525
14
116
Kela drug reimbursment
Prostate cancer
+∞
323.0
1434
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
323.0
877
*
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
6.7
323.0
1193
1987
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
5527.7
323.0
578
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
6043.8
323.0
623
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
323.0
3927
*
KC1GB
NOMESCO Finland
Cystography with X-ray
289.6
323.0
375
12
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.6
323.0
1790
4982
H02AB02
ATC
dexamethasone; systemic
33.3
304.9
426
119
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
709.2
301.1
314
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
359.0
299.5
319
8
G04BE03
ATC
sildenafil; oral
41.2
297.9
397
89
JN4BD
NOMESCO Finland
Extensive body CT
8.9
297.6
706
783
KE1DG
NOMESCO Finland
Very extensive MRI of prostate
32.3
289.9
408
117
J01EA01
ATC
trimethoprim; systemic
7.0
287.2
805
1155
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
447.3
282.8
299
6
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
279.5
284
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
279.5
284
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
2312.1
261.2
268
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
803.7
259.2
270
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2274.1
257.2
264
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
255.6
260
*
G04BE01
ATC
alprostadil; parenteral, urethral
28.7
253.2
367
117
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
237.7
242
*
KE1BG
NOMESCO Finland
MRI of prostate
37.9
229.4
311
74
JN4AD
NOMESCO Finland
Body CT examination
9.4
225.3
511
511
KDE20
NOMESCO Finland
Removal of foreign body from urethra
71.6
223.9
272
34
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
162.2
213.0
238
13
A04AA02
ATC
granisetron; systemic, transdermal
279.4
203.4
220
7
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
26.7
195.8
289
97
L02BB04
ATC
enzalutamide; oral
+∞
195.0
199
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
194.0
198
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
1595.5
184.9
191
*
L02AE04
ATC
triptorelin; parenteral
+∞
181.2
185
*
KE1CG
NOMESCO Finland
Extensive MRI of prostate
43.8
173.2
228
46
130
Kela drug reimbursment
Malignant tumour
+∞
169.3
173
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
24.8
168.7
254
91
XJH00
NOMESCO Finland
Transanal ultrasonography
5.7
165.0
530
868
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
164.6
1312
4790
KEB00
NOMESCO Finland
Biopsy of prostate
38.2
163.4
221
51
B01AB05
ATC
enoxaparin; parenteral
2.8
157.5
1308
4873
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
156.5
160
*
M05BX04
ATC
denosumab; parenteral
22.8
153.6
237
92
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.3
153.5
954
2908
WZC30
NOMESCO Finland
Teaching
3.9
147.9
715
1775
G04CA02
ATC
tamsulosin; oral
2.5
146.4
1599
6935
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
39.0
145.6
196
44
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
143.7
147
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.6
141.5
561
1152
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.7
136.7
273
208
L03AA13
ATC
pegfilgrastim; parenteral
1191.4
131.7
137
*
UKC02
NOMESCO Finland
Cystoscopy
3.2
131.2
837
2565
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
1181.2
130.8
136
*
ZX080
NOMESCO Finland
Image guided radiotherapy
576.6
127.0
134
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
123.0
126
*
N40
ICD-10 Finland
Hyperplasia of prostate
2.4
122.0
1447
6394
TKE10
NOMESCO Finland
Puncture of prostate
229.9
121.5
133
5
J01MA02
ATC
ciprofloxacin; systemic
2.3
121.3
1742
8454
N39.3
ICD-10 Finland
Stress incontinence
85.7
117.1
139
14
WX402
NOMESCO Finland
General anaesthesia
3.0
115.8
820
2672
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
271.0
115.2
125
*
L02BX03
ATC
abiraterone; oral
+∞
115.2
118
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
113.2
116
*
G04BE30
ATC
drugs used in erectile dysfunction - combinations
338.9
110.8
119
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
259.4
110.3
120
*
OAB42
NOMESCO Finland
Guidance related to known health problem
120.5
109.9
126
9
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
107.3
110
*
TQW40
NOMESCO Finland
Remowal of suture of skin
4.1
106.3
465
1035
WF004
NOMESCO Finland
Palliative radiotherapy
933.2
104.3
109
*
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
13.2
95.8
180
119
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
95.5
98
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
218.3
93.0
102
*
3054
Kela drug reimbursment
NA
+∞
92.6
95
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
92.6
95
*
1523
Kela drug reimbursment
NA
+∞
91.6
94
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
89.7
92
*
Z51.5
ICD-10 Finland
Palliative care
13.2
87.4
164
108
N02BE01
ATC
paracetamol; systemic, rectal
2.2
82.1
3263
22499
JN4LR
NOMESCO Finland
Extensive PET-CT of receptors in whole body
705.5
79.0
83
*
Z51.0
ICD-10 Finland
Radiotherapy session
688.1
77.0
81
*
TKC52
NOMESCO Finland
Patient education concerning pelvic floor contraction exercises
174.4
73.7
82
*
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
224.4
72.1
79
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
72.1
74
*
JN4CD
NOMESCO Finland
Very extensive body CT
7.6
69.1
174
199
ZX112
NOMESCO Finland
Subcutaneous
14.1
69.0
125
76
N42.9
ICD-10 Finland
Disorder of prostate, unspecified
6.8
67.4
182
231
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
65.2
67
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
65.2
67
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
575.4
64.4
68
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
290.6
63.9
69
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
63.3
65
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
60.5
1780
10435
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
41.9
60.0
79
16
A04AA01
ATC
ondansetron; systemic, rectal
7.8
59.8
147
162
G04BD12
ATC
mirabegron; oral
3.0
57.3
373
1114
R31
ICD-10 Finland
Unspecified haematuria
2.6
55.4
448
1529
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
54.4
1564
9003
A79
ICPC
Malignancy NOS
246.6
53.3
58
*
Y06
ICPC
Prostate symptom/complaint
4.0
53.0
228
492
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
16.0
52.4
90
48
L02AE03
ATC
goserelin; implant
454.9
50.8
54
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
38.4
50.8
68
15
U04
ICPC
Incontinence urine
6.5
50.6
140
184
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
50.6
52
*
TKC20
NOMESCO Finland
Catheterisation of bladder
3.1
50.3
304
860
ZX050
NOMESCO Finland
Stereotactic radiotherapy
45.9
50.3
65
12
N02AA05
ATC
oxycodone; systemic
2.6
48.8
413
1441
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
47.6
49
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
20.9
47.4
74
30
G03HA01
ATC
cyproterone; systemic
31.1
47.1
66
18
KCC10
NOMESCO Finland
Cystoprostatectomy
215.5
46.6
51
*
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
67.7
46.1
56
7
KD1GB
NOMESCO Finland
Uretrocystogpaphy with X-ray
39.7
46.0
61
13
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
45.7
47
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
45.7
47
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
45.7
47
*
L01BC06
ATC
capecitabine; oral
+∞
45.7
47
*
B01AB10
ATC
tinzaparin; parenteral
3.6
45.0
220
530
WB221
NOMESCO Finland
Demanding neoadjuvant hormone therapy of malignancy
+∞
43.8
45
*
KDG43
NOMESCO Finland
Transobturatorial sling urethrocystopexy
+∞
43.8
45
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
43.8
45
*
R33
ICD-10 Finland
Retention of urine
2.7
43.4
333
1096
XX1AD
NOMESCO Finland
Other CT-examination
73.2
43.3
52
6
KE1DR
NOMESCO Finland
Prostate metabolic PET with CT
+∞
42.8
44
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
103.4
42.4
49
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
369.2
41.2
44
*
L03AA02
ATC
filgrastim; parenteral
47.8
39.9
51
9
A04AD12
ATC
aprepitant; systemic
+∞
39.9
41
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
38.4
395
1520
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
37.9
39
*
XKG00
NOMESCO Finland
Artificial induction of erection
29.8
37.6
53
15
G04CA01
ATC
alfuzosin; oral
1.8
37.3
809
4166
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
326.5
36.4
39
*
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
34.4
36.0
49
12
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
36.0
37
*
KDW96
NOMESCO Finland
Other operations on urethra
72.5
35.8
43
5
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.0
35.6
153
330
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
47.4
35.2
45
8
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
309.4
34.4
37
*
J01MA12
ATC
levofloxacin; systemic
1.8
34.0
649
3192
XX7FT
NOMESCO Finland
Radioyttrium therapy with connected antibody
+∞
34.0
35
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
34.0
35
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
109.4
34.0
39
*
TKC22
NOMESCO Finland
Catheterisation instruction
4.2
33.7
135
273
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
300.9
33.5
36
*
WVA20
NOMESCO Finland
Medicine administration
4.6
33.2
123
230
G04BD08
ATC
solifenacin; oral
3.1
32.5
195
548
Z12.5
ICD-10 Finland
Special screening examination for neoplasm of prostate
8.6
32.5
74
73
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
32.1
33
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
48.1
31.4
40
7
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
11.8
31.1
60
43
2BX02
NOMESCO Finland
NA
+∞
31.1
32
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
31.1
32
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
31.1
32
*
G04BE09
ATC
vardenafil; oral
46.9
30.5
39
7
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
46.9
30.5
39
7
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
266.8
29.6
32
*
R86.1
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of hormones
10.7
28.3
57
45
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
28.2
29
*
A06AH03
ATC
naloxegol; oral
19.5
27.9
44
19
R74.9
ICD-10 Finland
Abnormal level of unspecified serum enzyme
10.7
27.9
56
44
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
253.6
27.7
30
*
ZXC20
NOMESCO Finland
Use of chemical agents
8.9
27.0
60
57
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
26.2
27
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.6
26.1
80
122
WW500
NOMESCO Finland
Blood transfusion
4.4
25.6
98
191
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
25.3
26
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
25.3
26
*
WF099
NOMESCO Finland
Other radiotherapy
25.2
24.7
36
12
KED22
NOMESCO Finland
Transurethral resection of prostate
2.4
24.6
223
803
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
10.3
24.5
50
41
WX704
NOMESCO Finland
Intubation
2.2
24.3
254
977
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
5.4
24.0
75
117
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
23.8
244
932
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
23.3
24
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
209.8
22.9
25
*
XKD03
NOMESCO Finland
Urethral pressure profilometry
5.2
22.5
72
116
1CD02
NOMESCO Finland
NA
+∞
22.3
23
*
ZX022
NOMESCO Finland
LDR radiotherapy within tissue
+∞
22.3
23
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
22.1
656
3635
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
72.7
21.8
26
*
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
5.2
21.7
70
114
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
21.4
22
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
21.4
22
*
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
19.8
21.2
33
14
PJA12
NOMESCO Finland
Sentinel node biopsy
192.8
21.0
23
*
KE1DM
NOMESCO Finland
Very extensive MRI of prostate (more than 1.5 T)
69.9
20.9
25
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
20.4
21
*
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
5.7
20.2
60
89
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
184.3
20.0
22
*
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
18.6
19.6
31
14
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
175.9
19.1
21
*
WX110
NOMESCO Finland
Local anesthesy
1.4
18.9
2340
16994
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
18.8
270
1189
WX725
NOMESCO Finland
Noninvasive ventilation
2.3
18.5
173
634
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
18.4
19
*
N30.4
ICD-10 Finland
Irradiation cystitis
+∞
18.4
19
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
18.0
509
6050
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
+∞
17.5
18
*
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
+∞
17.5
18
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
17.5
18
*
R4110
NOMESCO Finland
Physiotherapy
1.5
17.4
825
5054
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
17.4
247
1084
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
18.9
17.2
27
12
KE1AE
NOMESCO Finland
Percutaneous utlrasound examination fo prostata
8.2
17.1
39
40
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
17.0
318
1537
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.9
16.9
106
308
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.0
16.7
102
293
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
25.1
16.7
24
8
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
79.6
16.2
19
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.2
16.1
63
127
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
15.8
316
1558
XX1XQ
NOMESCO Finland
Other SPECT-CT
+∞
15.5
16
*
OAB77
NOMESCO Finland
Discussion on exercise habits and instruction concerning use of sports and fitness services
+∞
15.5
16
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
15.5
16
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
53.0
15.4
19
*
NK6SN
NOMESCO Finland
Bone SPECT
75.4
15.3
18
*
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
23.0
15.0
22
8
TJF80
NOMESCO Finland
Ostomy education
10.6
14.7
29
23
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
14.6
15
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
133.9
14.3
16
*
R39.1
ICD-10 Finland
Other difficulties with micturition
2.2
14.1
141
536
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
14.1
1388
9570
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
14.1
522
3025
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
37.6
13.8
18
*
ZX100
NOMESCO Finland
Oral
4.7
13.7
47
84
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
13.6
14
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
13.6
14
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
13.6
14
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
13.6
14
*
XKC03
NOMESCO Finland
Water cystometry
2.9
13.5
82
235
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.5
13.5
111
381
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
125.5
13.4
15
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
125.5
13.4
15
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.2
13.3
143
562
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
30.1
13.2
18
5
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
6.4
13.2
35
46
KA3EB
NOMESCO Finland
Antegrade pyelography
8.4
12.6
28
28
C61, D400
ICD-10 Finland
NA
+∞
12.6
13
*
KE2KT
NOMESCO Finland
Marker implantation in prostate under radiological guidance
+∞
12.6
13
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
12.6
13
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
12.6
13
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.6
12.6
58
137
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
62.8
12.5
15
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.9
12.4
188
847
N99.1
ICD-10 Finland
Postprocedural urethral stricture
8.1
12.4
28
29
JN6AD
NOMESCO Finland
CT of torso and neck
7.6
12.3
29
32
R50.9
ICD-10 Finland
Fever, unspecified
1.6
12.3
342
1850
R86.9
ICD-10 Finland
Abnormal findings in specimens from male genital organs, unspecified abnormal finding
13.5
12.0
21
13
OAB75
NOMESCO Finland
Nutritional guidance related to maintaining health
41.8
11.8
15
*
WVA30
SPAT
NA
2.3
11.7
112
418
D07.5
ICD-10 Finland
Carcinoma in situ: Prostate
+∞
11.6
12
*
KE2JT
NOMESCO Finland
Demanding radiation source placement in prostate under ultrasound guidance
+∞
11.6
12
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
11.6
12
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
11.6
12
*
XX7AT
NOMESCO Finland
Radiation therapy with Radium-223
+∞
11.6
12
*
U76
ICPC
Malignant neoplasm of bladder
108.7
11.5
13
*
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
5.2
11.4
35
56
ZX136
NOMESCO Finland
Intravesicalis
11.7
11.3
21
15
SPAT1262
SPAT
Handing over of treatment supplies
1.4
11.2
630
3954
U08
ICPC
Urinary retention
2.9
11.1
68
197
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.5
11.1
93
1495
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
11.0
11.0
21
16
KCW96
NOMESCO Finland
Other operations on bladder
8.4
10.9
24
24
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
10.7
261
1365
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
54.3
10.7
13
*
U77
ICPC
Malignant neopl urinary tract other
+∞
10.7
11
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
10.7
11
*
KDK10
NOMESCO Finland
Implantation of artificial urinary sphincter around bulbar urethra
+∞
10.7
11
*
WB211
NOMESCO Finland
Neoadjuvant hormone therapy of malignancy
+∞
10.7
11
*
WB201
NOMESCO Finland
Simple neoadjuvant hormone therapy of malignancy
+∞
10.7
11
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.2
10.7
111
430
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.2
10.6
11
444
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
11.2
10.6
20
15
C90.0
ICD-10 Finland
Multiple myeloma
100.3
10.6
12
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
100.3
10.6
12
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
100.3
10.6
12
*
103
Kela drug reimbursment
Diabetes, insulin-treated
0.7
10.5
674
7095
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
10.4
87
305
G04CB02
ATC
dutasteride; oral
1.6
10.3
249
1298
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.7
10.2
196
958
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
20.9
10.1
15
6
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
4.8
10.0
33
58
KA1FN
NOMESCO Finland
Isotope renography
5.7
9.9
28
41
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
9.9
447
4948
KE2AT
NOMESCO Finland
Cytologoy of prostata with ultrasound guidance
50.1
9.8
12
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
6.9
9.8
24
29
L02BB01
ATC
flutamide; oral
+∞
9.7
10
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
9.7
10
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
9.7
10
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
9.7
10
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
9.7
10
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
91.9
9.6
11
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
14.9
9.6
16
9
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.5
9.6
338
1933
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.6
9.6
68
219
N48.4
ICD-10 Finland
Impotence of organic origin
1.9
9.4
137
613
WX600
NOMESCO Finland
Single shot through catheter
6.5
9.4
24
31
N05AA02
ATC
levomepromazine; systemic
0.4
9.2
51
938
ZX120
NOMESCO Finland
Intravenous
1.7
9.2
200
1016
N35.9
ICD-10 Finland
Urethral stricture, unspecified
2.8
9.0
57
171
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
6.4
8.9
23
30
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
7.3
8.9
21
24
B01AC04
ATC
clopidogrel; oral
0.7
8.9
304
3530
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.8
8.8
668
6898
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
8.7
9
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
8.7
9
*
D63.0
ICD-10 Finland
Anaemia in neoplastic disease
+∞
8.7
9
*
ZX137
NOMESCO Finland
To penis
+∞
8.7
9
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
8.7
9
*
4194
NOMESCO Finland
NA
83.6
8.7
10
*
WF001
NOMESCO Finland
Preoperative radiotherapy
83.6
8.7
10
*
N30.9
ICD-10 Finland
Cystitis, unspecified
2.6
8.7
63
206
N05AX08
ATC
risperidone; systemic
0.5
8.6
58
995
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
0.3
8.6
16
464
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.2
8.5
12
403
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
5.6
8.4
24
36
U06
ICPC
Haematuria
2.6
8.4
61
200
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
0.5
8.3
69
1105
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
0.3
8.1
22
534
N05AC02
ATC
thioridazine; oral
0.2
8.1
11
378
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
20.1
8.1
12
5
OAA41
NOMESCO Finland
Health check based on individual needs
41.8
8.0
10
*
A10AA02
ATC
NA
0.3
7.9
19
487
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.0
7.9
104
449
WW200
SPAT
NA
0.7
7.8
180
2246
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
75.2
7.8
9
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
75.2
7.8
9
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
75.2
7.8
9
*
N42.8
ICD-10 Finland
Other specified disorders of prostate
4.1
7.8
29
59
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
7.8
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
7.8
8
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
7.8
8
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
7.8
8
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
7.8
8
*
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
7.8
8
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
7.8
8
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
7.8
8
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
7.8
8
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.8
8
*
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
+∞
7.8
8
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
7.8
8
*
5BX04
NOMESCO Finland
NA
+∞
7.8
8
*
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
8.9
7.7
16
15
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
23.0
7.7
11
*
ECB20
NOMESCO Finland
Oral alveoplasty
3.1
7.7
40
107
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
7.7
3379
26997
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
16.7
7.6
12
6
N03AG01
ATC
valproic acid; systemic, rectal
0.5
7.6
61
992
P72
ICPC
Schizophrenia
0.2
7.6
10
349
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
14.3
7.3
12
7
SPAT1153
SPAT
Removal of sutures
1.2
7.2
923
6465
WX320
NOMESCO Finland
Spinalanesthesy
1.3
7.2
615
4096
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
0.5
7.2
64
1004
A10BA02
ATC
metformin; oral
0.8
7.2
735
7345
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
3.4
7.1
33
82
TQX05
NOMESCO Finland
Skin puncture, unspecified location
8.4
7.1
15
15
U99
ICPC
Urinary disease other
4.5
7.0
24
45
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
6.8
7.0
17
21
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
6.8
7.0
17
21
U28
ICPC
Limited function/disability (U)
3.8
6.9
28
62
N05AB03
ATC
perphenazine; systemic, rectal
0.4
6.9
33
633
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
0.5
6.8
53
868
C07AB07
ATC
bisoprolol; oral
0.8
6.8
1196
11339
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
6.8
7
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
6.8
7
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
+∞
6.8
7
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
6.8
7
*
8000/3-C61.9
ICD-O-3
Neoplasm, malignant of prostate gland
+∞
6.8
7
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.8
7
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
6.8
7
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
6.8
7
*
Y78
ICPC
Malign neopl male genital other
+∞
6.8
7
*
Y77
ICD-10 Finland
Ophthalmic devices associated with adverse incidents
+∞
6.8
7
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
6.8
7
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
6.8
7
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
6.8
7
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
6.8
205
1138
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
2.9
6.8
39
112
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
6.8
142
716
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.9
6.7
87
376
R32
ICD-10 Finland
Unspecified urinary incontinence
3.2
6.7
33
86
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
0.3
6.7
15
395
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.4
6.7
56
200
N30.0
ICD-10 Finland
Acute cystitis
1.7
6.6
121
588
A10AA01
ATC
NA
0.3
6.6
17
422
KH1AD
NOMESCO Finland
CT of urinary organs
1.7
6.6
129
637
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
6.6
1251
9124
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
0.4
6.6
24
516
U13
ICPC
Bladder symptom/complaint other
2.7
6.6
43
134
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.8
6.6
117
564
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
3.1
6.6
34
92
N05AH02
ATC
clozapine; systemic
0.3
6.5
11
334
N41.0
ICD-10 Finland
Acute prostatitis
1.7
6.5
116
560
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
13.1
6.5
11
7
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.2
6.5
32
84
WX290
NOMESCO Finland
Other blockade of nerve
1.2
6.3
1388
10259
UJF32
NOMESCO Finland
Coloscopy
1.3
6.3
637
4334
J01CA08
ATC
pivmecillinam; oral
1.8
6.2
106
502
WX872
NOMESCO Finland
Intensive care
0.6
6.2
87
1210
G04BE08
ATC
tadalafil; oral
8.4
6.2
13
13
N13.8
ICD-10 Finland
Other obstructive and reflux uropathy
18.8
6.1
9
*
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
2.9
6.0
35
102
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
7807
32278
1.96
314.68
7.7
4.2
umol/l
11.7
13.5
31.29
7502
30441
(3031040) Bacteria [#/volume] in Urine by Automated count
10602
39966
3.13
307.65
5.2
3.7
e6/l
288.6
603.1
0.73
207
764
(3018095) Leukocytes [#/volume] in Urine
6542
23343
2.23
307.65
4.6
3.5
e6/l
77.3
97.9
0.96
5399
17235
(3000850) Epithelial cells [#/volume] in Urine
4539
14327
2.30
307.65
3.0
2.5
e6/l
2.5
2.7
0.79
4063
12441
(3017446) Testosterone [Moles/volume] in Serum or Plasma
4035
8119
3.73
307.65
2.2
2.2
nmol/l
8.0
14.9
307.65
3462
7178
(4035726)
1547
1942
5.22
307.65
1.3
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
8029
31235
2.19
307.65
4.8
2.7
ug/l
1.1
0.7
43.49
6367
21265
(3002582) Erythrocytes [#/volume] in Urine
6275
20909
2.40
307.65
4.2
3.1
e6/l
139.3
115.3
0.32
5246
16189
(3037467) Urinalysis macro (dipstick) panel - Urine
9916
44023
2.08
307.65
4.7
3.7
—
—
—
0
0
(3002256) Pathology report gross observation
2311
5093
3.04
307.65
1.4
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
5629
19003
2.26
307.65
3.9
3.0
e6/l
0.3
0.5
7.29
4584
14259
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
11302
49429
2.61
307.65
9.7
5.6
u/l
82.4
76.0
17.19
10908
45946
(36304419) Bacteria [Presence] in Urine
5336
17970
2.23
307.65
3.9
3.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
10200
44444
2.23
307.65
8.0
3.7
%
15.3
24.0
307.65
7212
21418
(40768804) Tissue Pathology biopsy report
5858
17874
2.61
307.65
2.3
1.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
7283
24857
2.50
307.65
4.0
3.2
—
0.7
—
0
8
(3026008) Bacteria identified in Urine by Culture
4786
14479
2.46
307.65
3.5
2.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
7323
28705
2.06
307.65
4.5
3.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
12418
55573
3.20
307.65
12.0
3.9
ug/l
10.0
2.2
21.67
11090
50138
(40768800) Prostate Pathology biopsy report
4154
1026
33.46
307.65
1.2
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
4191
13157
2.27
307.65
3.3
2.6
mosm/kgh2o
607.0
589.8
5.27
3710
11068
(3015377) Calcium [Moles/volume] in Serum or Plasma
5020
18004
2.02
298.29
4.5
2.1
mmol/l
2.3
2.3
5.50
4486
15072
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
566
481
7.30
297.50
2.4
1.3
ug/l
23.5
19.5
0.67
554
469
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1612
3509
2.97
283.54
3.9
1.5
ug/l
23.4
8.9
1.54
1332
2666
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
3448
11014
2.15
273.57
3.9
2.8
e6/l
0.6
0.8
2.88
2178
6180
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
385
255
9.27
240.96
2.8
1.8
nmol/l
6.3
5.5
0.17
380
247
(3044640) Blood type and Crossmatch panel - Blood
4895
18843
1.84
220.67
2.7
2.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
3480
11959
1.98
220.57
3.6
2.6
e6/l
0.8
0.9
2.20
2198
7067
(3049717) Cytology report of Urine Cyto stain
1358
3091
2.80
218.50
3.0
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
7096
31605
1.67
181.40
8.1
6.6
mmol/l
1.2
1.2
2.63
5910
26634
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
6489
28785
1.63
161.81
7.0
6.3
mmol/l
1.2
1.2
4.80
5880
25757
(3013650) Neutrophils [#/volume] in Blood by Automated count
7427
34174
1.61
158.57
9.5
6.4
e9/l
4.3
4.5
6.29
6491
29249
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
3735
14625
1.71
146.49
2.6
2.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
6131
27269
1.60
146.32
5.1
4.2
g/l
34.5
35.1
10.25
5671
25073
(3013826) Glucose [Moles/volume] in Serum or Plasma
8484
41452
1.54
126.74
4.9
5.1
mmol/l
6.9
7.0
10.91
8061
38932
(3032080) INR in Blood by Coagulation assay
6678
31127
1.53
121.97
10.3
11.4
inr
1.3
1.4
4.95
1996
8442
(3030981) Hyaline casts [#/volume] in Urine by Automated count
1393
4179
2.10
121.03
3.6
2.6
e6/l
0.2
0.3
2.54
1373
4118
(3003694) ABO and Rh group [Type] in Blood
3904
16349
1.59
112.44
1.3
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
4129
17783
1.55
103.63
5.2
3.7
ph
7.4
7.4
0.82
913
3302
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2576
10024
1.66
97.67
3.6
2.0
mmol/l
2.5
2.4
14.90
2262
8450
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2065
7571
1.74
97.33
4.7
2.7
u/l
252.8
241.6
1.74
1967
7051
(3023368) Bacteria identified in Blood by Culture
4612
20625
1.50
95.40
4.7
4.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
3725
16072
1.52
90.28
3.5
3.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
6533
31530
1.44
89.72
3.9
3.3
estimate
0.0
0.0
2.03
1469
5096
(3021601) Nitrite [Presence] in Urine by Test strip
6435
31087
1.43
86.91
5.1
4.3
estimate
0.0
0.0
0.50
1535
5543
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
554
1277
2.66
85.34
3.0
2.0
u/ml
907.4
112.1
1.95
466
1056
(3035350) Ketones [Presence] in Urine by Test strip
6447
31280
1.42
83.97
3.8
3.3
estimate
0.0
0.0
0.50
1496
5340
(40758558) Short blood count panel - Blood
3378
14475
1.52
83.38
7.5
4.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
11927
65046
1.53
80.04
18.3
14.4
mg/l
29.9
27.5
9.28
10009
51949
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
11547
62552
1.50
79.85
19.5
13.4
ml/min/173m2
75.3
76.5
8.04
10193
51178
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
5125
24441
1.40
69.38
4.1
3.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
1394
5005
1.74
69.12
4.0
3.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
12615
70266
1.54
66.80
21.6
17.7
mmol/l
139.6
139.8
14.67
12345
68443
(3013512) EKG study
4588
21646
1.39
65.08
4.2
4.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
3582
16179
1.43
65.03
4.2
4.0
%
85.0
81.2
15.69
3520
15810
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1819
7119
1.61
64.94
3.7
3.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
12629
70457
1.54
64.71
21.8
17.8
mmol/l
4.0
4.0
5.56
12344
68559
(3029937) Albumin [Presence] in Urine by Test strip
3799
17575
1.40
59.24
4.2
3.6
estimate
0.0
0.0
0.05
1386
5088
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
3672
16985
1.40
56.87
2.1
2.3
mg/l
3.0
2.9
0.88
3103
14355
(3020564) Creatinine [Moles/volume] in Serum or Plasma
12612
70816
1.48
54.80
24.2
16.9
umol/l
91.0
89.9
2.38
12607
70783
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1322
4979
1.65
54.41
5.1
3.5
mmol/l
1.2
1.2
0.97
1158
4291
(40761511) CBC panel - Blood by Automated count
12133
67700
1.43
53.32
18.9
14.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
5893
29585
1.32
52.86
5.7
5.8
%
24.5
25.8
15.02
5423
27278
(3019225) pH of Specimen
1585
6308
1.57
51.97
4.9
3.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
5756
28926
1.32
50.51
5.8
5.9
%
9.2
9.1
0.62
5334
26836
(3006504) Eosinophils/100 leukocytes in Blood
5721
28775
1.32
49.60
5.5
5.7
%
2.9
3.0
2.78
5287
26612
(42870588) Differential panel, method unspecified - Blood
4364
21143
1.34
48.94
5.5
5.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
5550
27948
1.31
46.86
5.6
5.7
%
0.6
0.7
7.13
5134
25890
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2315
10182
1.43
46.36
3.2
2.9
mmol/l
0.8
0.8
2.21
2192
9406
(3018010) Neutrophils/100 leukocytes in Blood
5757
29193
1.30
45.83
5.5
5.6
%
59.7
58.6
8.63
5329
27095
(3014576) Chloride [Moles/volume] in Serum or Plasma
2187
9556
1.44
45.27
6.8
7.7
mmol/l
104.8
104.5
1.83
2159
9286
(3001122) Ferritin [Mass/volume] in Serum or Plasma
4704
23365
1.31
42.84
2.8
2.9
ug/l
246.3
183.9
12.94
4206
21346
(3021589) Normoblasts [#/volume] in Blood
5556
28217
1.29
42.76
12.1
9.0
e9/l
0.0
0.0
0.20
4642
23217
(3015736) pH of Urine
4877
24402
1.30
41.78
3.6
3.1
ph
5.9
5.4
1.98
35
17
(3007461) Platelets [#/volume] in Blood
12757
72628
1.41
38.84
28.6
20.9
e9/l
229.8
228.0
2.48
12486
70250
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
12427
70445
1.38
38.75
12.3
9.4
u/l
26.7
28.7
11.12
11946
67504
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
53
27
11.81
38.62
7.2
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
12758
72648
1.41
38.61
28.4
20.8
pg
30.7
30.7
4.03
12607
71279
(3024731) MCV [Entitic volume]
12759
72666
1.40
38.41
28.5
20.8
fl
91.9
91.7
3.11
12610
71289
(3010813) Leukocytes [#/volume] in Blood
12760
72673
1.40
38.40
28.6
20.9
e9/l
6.8
6.9
3.31
12446
69997
(3026361) Erythrocytes [#/volume] in Blood
12759
72667
1.40
38.39
28.6
20.9
e12/l
4.4
4.6
181.89
12436
69976
(3000963) Hemoglobin [Mass/volume] in Blood
12760
72677
1.40
38.33
28.7
21.0
g/l
134.9
140.5
247.92
12599
71307
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
306
784
2.37
38.06
2.9
1.9
u/ml
155.0
1361.7
0.85
276
705
(40761535) Cells panel - Urine sediment
1451
6050
1.49
37.73
3.5
3.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
268
653
2.49
37.07
1.3
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
1535
6517
1.46
36.38
1.4
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
97
121
4.83
36.00
1.2
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1057
4174
1.56
35.27
7.6
11.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
1253
5210
1.48
32.83
3.4
3.7
%
1.2
0.8
3.82
420
1241
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
4096
20521
1.27
32.74
2.6
2.4
u/l
59.3
61.8
1.31
3764
18911
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1514
6553
1.43
32.18
2.8
2.5
umol/l
8.5
9.5
1.04
1343
5820
(1761482) Bacteria [#/volume] in Urine by Culture
578
2003
1.76
31.84
4.5
3.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
6050
31851
1.24
30.84
5.5
5.5
e9/l
1.7
1.8
1.86
5217
27653
(3001604) Monocytes [#/volume] in Blood
5890
30995
1.23
29.79
5.3
5.4
e9/l
0.6
0.7
1.84
4977
26453
(3006315) Basophils [#/volume] in Blood
5923
31207
1.23
29.52
5.3
5.4
e9/l
0.0
0.0
15.04
5021
26679
(3013115) Eosinophils [#/volume] in Blood
6089
32181
1.23
29.44
5.5
5.6
e9/l
0.2
0.2
9.22
5221
27853
(3021440) Promyelocytes/100 leukocytes in Blood
1186
4984
1.46
29.35
3.4
3.7
%
0.1
0.1
1.50
392
1150
(3004809) Band form neutrophils/100 leukocytes in Blood
305
874
2.12
29.29
3.2
3.0
%
1.8
1.5
0.45
213
648
(3027945) Reticulocytes/100 erythrocytes in Blood
1922
8797
1.36
29.18
2.5
2.1
%
1.8
1.7
0.84
1674
7703
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2453
11710
1.31
27.78
1.9
1.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
1491
6598
1.40
27.75
2.8
2.2
e9/l
67.9
67.9
0.02
1158
5055
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1210
5182
1.44
27.05
2.2
2.1
g/l
0.2
0.2
0.99
1110
4687
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3984
20250
1.25
27.03
3.6
2.8
u/l
35.2
37.6
0.86
3761
19022
(3002179) Metamyelocytes/100 leukocytes in Blood
1122
4747
1.45
26.74
3.3
3.6
%
1.1
0.6
2.94
298
914
(3022948) Iron [Moles/volume] in Serum or Plasma
2358
11309
1.30
25.57
2.6
2.7
umol/l
12.5
13.2
4.22
2169
10446
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2215
10535
1.31
25.56
2.6
2.7
g/l
2.2
2.2
3.61
2030
9722
(3025159) Blasts/100 leukocytes in Blood
1104
4707
1.44
25.22
3.4
3.8
%
0.0
0.2
0.92
332
990
(3002385) Erythrocyte distribution width [Ratio]
9449
52626
1.22
25.13
24.0
17.0
%
13.8
13.7
12.93
9315
51296
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2090
9919
1.31
24.40
2.7
2.8
%
23.0
23.7
1.31
1738
8383
(3021960) Folate [Moles/volume] in Serum or Plasma
3333
16771
1.25
24.24
1.6
1.6
nmol/l
18.4
18.9
1.12
2837
14418
(3044889) 12 lead EKG panel
8878
49259
1.20
23.82
4.3
4.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
10199
57351
1.22
23.81
20.3
15.7
%
38.9
40.5
31.10
6359
37532
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1017
4318
1.44
23.73
1.6
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
8575
47455
1.20
23.46
3.9
3.9
mm/h
14.4
11.7
34.10
7735
43636
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
71
99
4.32
23.41
1.1
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
1800
8470
1.31
22.20
6.8
8.3
%
95.7
95.0
4.70
1702
8177
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1627
7570
1.32
21.71
7.2
9.0
g/l
121.5
125.0
9.33
1549
7320
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
776
3183
1.49
21.57
2.0
2.0
ug/l
3.6
2.1
1.16
671
2824
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
956
4103
1.42
21.00
8.3
10.8
mmol/l
23.8
24.3
4.92
904
3724
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
66
98
4.05
20.23
5.7
1.1
u/ml
36.4
156.8
0.50
22
14
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
248
758
1.98
20.22
1.5
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
1920
9239
1.28
19.86
6.6
8.0
mmol/l
0.5
1.1
7.88
1480
7178
(3000330) Specific gravity of Urine by Test strip
854
3627
1.44
19.85
4.1
3.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
1443
6691
1.33
19.62
6.7
8.0
mmol/l
1.4
1.5
1.39
1387
6428
(21494755) Public health laboratory ask at order entry panel
439
4126
0.63
19.49
1.4
1.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
1914
9238
1.28
19.29
6.6
8.0
kpa
12.2
11.4
9.44
1799
8815
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1913
9245
1.28
19.07
6.6
8.0
kpa
5.1
5.0
2.06
1795
8825
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1891
9128
1.28
19.02
6.1
6.7
mmol/l
1.0
1.0
0.41
1760
8510
(3022621) pH of Urine by Test strip
969
4245
1.39
18.92
3.0
2.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
699
2917
1.46
17.82
2.0
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
178
510
2.11
17.30
1.3
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
178
512
2.10
17.13
1.5
1.2
u/l
97.0
55.0
1.96
128
315
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
645
2680
1.46
16.83
1.9
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
1352
6399
1.29
15.72
8.2
9.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
265
909
1.76
15.30
1.5
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
190
586
1.96
15.23
3.2
3.0
%
60.2
62.6
0.54
108
375
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
18
0
+∞
15.21
1.1
0.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2356
11938
1.22
15.09
2.0
2.0
s
30.3
30.4
0.39
2289
11595
(3020630) Protein [Mass/volume] in Serum or Plasma
1289
6132
1.29
14.37
2.7
1.7
g/l
65.7
66.9
6.38
1164
5581
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
622
2661
1.42
13.93
2.8
3.1
u/ml
0.4
0.3
1.09
350
1568
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
946
4334
1.33
13.89
6.3
8.6
mmol/l
24.3
24.6
1.28
940
4284
(3008757) Leukocyte morphology finding [Identifier] in Blood
201
654
1.85
13.81
3.8
3.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
4449
23983
1.16
13.77
3.0
3.2
ng/l
1878.9
1688.8
1.27
3840
20849
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1812
9033
1.23
13.49
4.7
5.0
%
31.3
31.5
0.37
1175
6271
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1218
5807
1.28
13.33
3.2
2.5
ml/min/173m2
64.4
62.5
0.82
484
2215
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
102
261
2.35
13.04
1.5
1.3
mg/l
4.3
4.3
0.04
93
253
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
5357
29366
1.15
12.94
4.0
4.0
ng/l
54.0
96.4
3.47
4346
22660
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
935
4324
1.32
12.86
1.8
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
746
3352
1.35
12.48
4.3
5.1
%
0.9
0.9
0.17
680
3176
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
4091
22055
1.16
12.35
2.0
2.1
nmol/l
78.7
75.6
9.09
3543
19379
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
754
3417
1.34
11.93
4.2
5.0
%
1.6
1.7
2.62
685
3242
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1100
5252
1.28
11.89
2.3
2.4
u/l
35.4
43.7
1.20
921
4463
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
215
752
1.73
11.73
1.1
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
106
290
2.20
11.70
1.9
1.5
u/l
7.6
5.5
0.63
53
125
(3019150) Specific gravity of Urine by Refractometry
2749
14427
1.18
11.64
4.3
3.6
kg/l
1.0
1.0
0.52
445
2105
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
96
255
2.27
11.36
1.2
1.1
u/l
20.7
24.1
0.34
58
192
(3012501) Base excess in Blood by calculation
416
1722
1.46
11.18
4.1
4.7
mmol/l
2.2
2.4
1.24
266
1139
(3013290) Carbon dioxide [Partial pressure] in Blood
416
1723
1.46
11.15
4.1
4.7
kpa
4.9
5.0
1.61
409
1674
(3035637) Corticotropin [Mass/volume] in Plasma
145
457
1.91
11.07
1.7
1.3
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
95
255
2.24
10.99
1.2
1.1
u/l
69.7
92.5
2.04
62
203
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
1047
5017
1.27
10.99
8.5
10.5
%
0.6
0.7
12.73
1038
4981
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
109
310
2.12
10.98
1.3
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1097
8096
0.80
10.85
1.8
1.9
%
1.7
1.6
0.43
903
6880
(3027315) Oxygen [Partial pressure] in Blood
416
1733
1.45
10.83
4.1
4.7
kpa
8.4
8.4
0.25
409
1683
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
799
3704
1.31
10.82
1.5
1.5
g/l
1.6
1.5
2.95
679
3153
(3020779) Urea [Moles/volume] in Serum or Plasma
1484
7409
1.22
10.79
6.9
8.0
mmol/l
11.5
11.3
0.40
1408
7015
(3019309) Folate [Moles/volume] in Red Blood Cells
2689
14188
1.17
10.54
1.8
1.8
nmol/l
1129.3
1128.2
0.02
1974
10820
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
374
1537
1.47
10.45
1.5
1.5
—
—
—
0
0
(3010421) pH of Blood
459
1962
1.42
10.42
4.0
4.7
ph
7.4
7.4
0.40
411
1675
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
376
1551
1.47
10.32
1.4
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
5354
29668
1.13
10.24
2.0
2.0
pmol/l
93.2
91.6
1.69
3074
17012
(3047181) Lactate [Moles/volume] in Blood
553
2448
1.37
10.22
5.0
6.3
mmol/l
1.3
1.4
0.71
463
2208
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
49
97
3.04
10.21
1.9
2.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
1045
5054
1.26
10.15
8.4
10.3
%
1.2
1.4
5.84
1037
5014
(3018572) Chloride [Moles/volume] in Blood
417
1762
1.43
10.10
5.4
7.1
mmol/l
105.0
105.1
0.18
358
1620
(3039000) Anion gap in Blood
417
1762
1.43
10.10
5.4
7.1
mmol/l
11.0
11.5
2.18
358
1620
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
87
234
2.24
10.06
2.9
3.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1611
8166
1.21
10.03
1.8
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
397
1668
1.44
9.92
2.4
2.6
%
16.0
16.8
2.53
225
919
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
282
1106
1.54
9.86
1.6
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
418
1778
1.42
9.78
3.8
4.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
2858
15235
1.16
9.69
3.8
3.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
359
1490
1.46
9.58
1.5
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1047
5108
1.25
9.43
3.5
3.6
mmol/l
1.6
1.6
0.05
748
3679
(3052851) Hemolysis interference index of Serum or Plasma
455
1982
1.39
9.31
3.6
3.6
—
—
—
0
0
(3009343) pH of Capillary blood
1079
5290
1.24
9.30
3.6
3.7
ph
7.4
7.4
0.00
158
642
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1093
5371
1.24
9.23
3.6
3.7
kpa
5.1
5.1
0.16
1001
4961
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
418
3430
0.72
9.17
1.6
1.7
nmol/l
44.2
44.1
0.05
404
3302
(40768443) Skin Pathology biopsy report
556
2507
1.34
9.17
1.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
864
4137
1.27
9.14
1.6
1.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
426
1846
1.40
9.00
2.8
3.0
kpa
7.8
7.9
0.09
397
1717
(3037756) Immunofixation for Serum or Plasma
361
1520
1.43
8.96
1.5
1.2
—
—
—
0
0
(4034850)
288
2506
0.68
8.90
13.2
11.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
76
206
2.22
8.70
1.9
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1596
8198
1.19
8.55
1.9
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
1060
5235
1.23
8.55
2.2
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
93
277
2.02
8.43
1.8
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
2420
12867
1.15
8.38
4.3
4.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
93
278
2.01
8.35
1.8
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
93
278
2.01
8.35
1.8
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
93
278
2.01
8.35
1.8
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
524
2383
1.33
8.20
2.9
1.6
ratio
3.8
2.6
0.43
42
187
(3045414) Leukocytes [Presence] in Urine
607
2821
1.30
8.14
2.1
1.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
14
5
16.81
8.08
1.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
74
205
2.17
8.07
1.9
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
74
206
2.16
7.99
1.9
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
11332
66020
1.13
7.95
5.0
5.1
mmol/l
6.1
6.2
10.45
10005
59956
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
7293
41509
1.11
7.85
3.2
3.1
u/l
57.9
57.5
0.12
6636
38148
(3021901) Oxygen saturation in Capillary blood
373
1620
1.39
7.83
2.7
2.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
48
111
2.60
7.72
1.2
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
419
1860
1.36
7.71
1.3
1.3
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
11
316
0.21
7.61
18.2
15.8
nmol/l
1513.2
1343.6
0.39
11
302
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
533
2458
1.31
7.59
2.9
1.6
mg/l
73.2
39.4
0.70
411
1970
(3014051) Protein [Presence] in Urine by Test strip
330
1413
1.41
7.54
2.6
2.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
28
47
3.58
7.52
1.4
1.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
83
248
2.01
7.51
2.4
2.2
e9/l
0.1
0.1
1.76
77
240
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
349
1511
1.39
7.49
1.7
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
533
2463
1.31
7.49
2.9
1.6
mg/l
66.7
54.1
0.62
408
1974
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
750
3619
1.26
7.48
4.2
4.5
mmol/l
23.7
23.9
0.82
666
3178
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
10
301
0.20
7.44
13.9
11.6
nmol/l
1077.3
812.6
—
10
284
(3011412) CD3 cells [#/volume] in Blood
109
361
1.82
7.32
2.4
2.1
e9/l
1.0
0.9
0.13
59
194
(3012441) Differential panel - Pleural fluid
203
799
1.53
7.12
1.5
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
740
3587
1.25
7.11
2.6
2.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
195
761
1.54
7.11
1.6
1.5
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
15
15
6.00
7.00
10.6
4.3
umol/l
0.3
0.3
—
15
8
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
9851
57093
1.11
6.92
3.7
3.7
mu/l
2.5
2.2
0.52
8569
51173
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
27
47
3.45
6.91
1.2
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
4353
28035
0.90
6.89
4.0
4.2
mg/mmol
9.2
9.3
0.04
2856
19378
(3012544) pH of Venous blood
1515
7887
1.17
6.89
4.1
4.1
ph
7.4
7.4
—
7
45
(3024522) Salmonella sp identified in Specimen by Organism specific culture
180
697
1.56
6.81
1.4
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
401
1805
1.34
6.80
2.8
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
231
1983
0.69
6.73
1.4
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
176
682
1.55
6.65
2.4
2.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
70
206
2.04
6.64
1.4
1.5
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
91
294
1.86
6.64
1.8
1.2
u/l
106.8
102.2
0.10
79
249
(3003434) Protein [Mass/volume] in Pleural fluid
251
1048
1.44
6.64
1.5
1.5
g/l
31.9
30.9
0.56
208
932
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
180
702
1.54
6.62
1.4
1.3
u/l
537.0
459.1
0.17
168
660
(40761539) Cells [Type] in Urine sediment by Light microscopy
58
159
2.19
6.57
1.1
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
249
2100
0.71
6.57
1.2
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
880
4393
1.21
6.44
2.5
1.8
nmol/l
368.7
358.8
0.61
819
3995
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
145
541
1.61
6.43
1.8
1.9
u/field
2.1
1.4
0.53
63
222
(3045788) Cell count panel - Pleural fluid
180
707
1.53
6.43
1.6
1.5
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
82
259
1.90
6.42
1.8
2.1
%
67.5
70.4
0.87
75
243
(3017732) Neutrophils [#/volume] in Blood
831
4128
1.22
6.39
2.7
3.0
e9/l
4.2
4.2
0.13
610
3014
(3002032) Base excess in Venous blood by calculation
1439
7513
1.16
6.31
4.1
4.1
mmol/l
1.6
1.7
0.53
1151
6084
(3028271) Lactate [Moles/volume] in Capillary blood
280
1205
1.40
6.30
1.8
2.0
mmol/l
1.8
1.8
0.24
273
1175
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
274
2258
0.72
6.29
1.2
1.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
86
278
1.86
6.29
1.9
1.2
u/l
32.1
26.2
0.29
74
234
(3005988) Vibrio sp identified in Specimen by Organism specific culture
176
694
1.53
6.19
1.4
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
176
694
1.53
6.19
1.4
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
113
1101
0.61
6.13
3.5
4.7
umol/l
324.5
350.4
1.24
87
922
(3012516) Albumin [Mass/volume] in Urine
4125
26509
0.91
6.07
3.2
3.4
mg/l
320.0
253.3
0.52
2723
18456
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
177
703
1.52
6.03
1.4
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
181
723
1.51
6.01
1.4
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
183
735
1.50
5.93
1.5
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
174
692
1.51
5.91
1.4
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
663
3245
1.24
5.90
3.9
4.0
mmol/l
24.6
24.6
0.05
602
2985
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
113
405
1.68
5.89
1.5
1.3
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
177
707
1.51
5.89
1.4
1.4
mmol/l
6.2
6.5
0.51
150
646
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1434
7526
1.16
5.87
4.1
4.1
kpa
5.8
5.8
1.57
1402
7302
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
18
26
4.16
5.87
1.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
540
2585
1.26
5.85
2.5
2.9
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
111
397
1.68
5.83
1.5
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
103
361
1.72
5.82
1.7
1.8
u/field
2.5
2.5
0.04
71
259
(3043410) Blood group antigens tested for on Red Blood Cells
58
168
2.07
5.79
2.1
1.6
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
145
559
1.56
5.67
1.3
1.3
u/l
15.2
13.5
0.24
132
518
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
108
388
1.67
5.60
1.4
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
217
1814
0.71
5.50
1.3
1.5
nmol/l
1.0
0.8
1.59
185
1493
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
77
253
1.83
5.42
1.8
2.1
%
22.4
17.1
1.10
25
101
(3028308) Erythrocytes [#/volume] in Pleural fluid
201
839
1.44
5.41
1.5
1.5
e6/l
57727.8
65762.6
0.16
124
515
(21494814) CD8 cells/100 lymphocytes in Specimen
50
141
2.13
5.36
1.6
2.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
73
237
1.85
5.34
1.8
2.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
4174
26680
0.91
5.32
3.1
3.4
mmol/l
8.3
8.6
2.91
3333
22453
(3023199) Leukocytes [#/volume] in Pleural fluid
218
928
1.41
5.29
1.5
1.5
e6/l
2049.6
3918.3
0.87
154
681
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
253
1106
1.38
5.26
4.1
7.2
iu/ml
5406.4
967.9
0.44
30
193
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
251
1097
1.38
5.23
5.9
6.2
mg/l
11.9
11.6
0.58
235
1010
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
140
547
1.54
5.21
1.5
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
250
1099
1.37
5.05
3.3
3.3
%
59.5
59.3
0.07
250
1099
(21494815) CD4 cells/100 lymphocytes in Specimen
96
345
1.67
5.02
1.8
2.3
%
42.4
44.0
0.11
17
44
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
343
2640
0.77
4.96
1.6
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
105
388
1.63
4.95
1.4
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
206
880
1.41
4.93
1.9
2.2
mg/l
24.7
27.2
0.20
52
247
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
460
2209
1.26
4.91
1.9
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
136
536
1.53
4.89
1.6
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
136
536
1.53
4.89
1.6
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
136
536
1.53
4.89
1.6
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1323
8963
0.87
4.87
1.2
1.2
iu/ml
32.0
45.0
1.92
367
2686
(3022217) INR in Platelet poor plasma by Coagulation assay
2154
11750
1.12
4.84
27.5
29.4
inr
1.5
1.5
0.54
336
1544
(3022313) Gas panel - Capillary blood
764
3876
1.19
4.78
3.9
3.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
22
332
0.40
4.72
1.1
1.3
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
11
9
7.34
4.62
4.5
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
20
38
3.16
4.59
1.1
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1205
8179
0.87
4.57
2.4
2.5
ug/l
7.2
9.5
3.00
1032
7295
(3000012) Reticulocyte production index
108
411
1.58
4.55
1.3
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
464
2255
1.24
4.50
3.0
3.2
mmol/l
24.5
24.5
0.01
406
2001
(3042936) Bacteria identified in Isolate by Culture
1913
10409
1.12
4.49
2.0
2.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1557
8371
1.13
4.48
1.3
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
71
243
1.76
4.46
1.7
1.9
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
41
116
2.12
4.42
1.6
2.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
153
634
1.45
4.37
1.6
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
135
548
1.48
4.28
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
618
4389
0.84
4.23
2.0
2.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
210
926
1.37
4.23
1.5
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
341
2570
0.79
4.21
2.2
2.3
ug/min
99.2
132.7
0.76
187
1572
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
88
826
0.64
4.20
1.4
1.2
nmol/l
1.4
1.4
0.02
79
751
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
75
266
1.69
4.19
2.8
2.0
e6/l
600.7
438.4
0.64
64
229
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
17
270
0.38
4.15
18.2
13.4
mmol/l
0.7
0.7
0.10
17
242
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
57
187
1.83
4.13
1.5
1.9
u/ml
2580.2
14775.1
—
5
30
(3005322) IgE [Units/volume] in Serum or Plasma
428
3138
0.81
4.11
1.3
1.3
u/ml
387.4
312.1
0.45
398
2934
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
13
233
0.33
4.11
2.2
2.8
nmol/l
122.4
136.6
0.27
13
203
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
230
1815
0.76
4.09
1.4
1.7
mg/l
3.3
4.3
0.80
168
1272
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
328
2474
0.79
4.09
1.8
1.9
pmol/l
179.9
198.9
1.99
300
2323
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
40
117
2.05
4.01
2.1
1.4
u/l
47.2
35.3
0.17
34
105
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
269
1242
1.30
4.00
1.3
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
152
1272
0.71
4.00
1.1
1.1
iu/ml
67.3
213.1
0.54
36
251
(3042631) Mycobacterium sp identified in Specimen
226
1019
1.34
3.97
2.4
2.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
241
1097
1.32
3.97
1.3
1.3
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
8
5
9.60
3.94
1.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
116
465
1.50
3.94
1.4
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
495
2459
1.21
3.94
2.3
1.6
g/l
1.3
0.5
3.26
418
2112
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
193
851
1.36
3.92
2.1
3.0
u/ml
582.3
11237.6
0.48
16
50
(3016879) Cocaine [Presence] in Urine
70
680
0.62
3.91
1.2
1.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
788
4083
1.17
3.89
2.7
2.1
g/l
10.7
11.3
2.07
707
3716
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
232
1814
0.76
3.88
1.5
1.6
iu/ml
24.9
3.8
0.50
58
418
(3006184) Hemoglobin [Mass/volume] in Capillary blood
382
1850
1.24
3.88
2.2
2.2
g/l
126.9
134.0
5.16
297
1362
(3000764) Benzodiazepines [Presence] in Urine
74
708
0.62
3.88
1.2
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
72
693
0.62
3.87
1.3
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
42
465
0.54
3.86
2.3
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
142
596
1.43
3.84
1.7
1.5
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
134
557
1.45
3.82
1.4
1.4
u/l
12.2
13.5
1.66
128
534
(3045424) Erythrocytes [Presence] in Urine
237
1083
1.32
3.82
1.5
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
220
997
1.33
3.76
1.3
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
10959
64415
1.08
3.76
6.4
6.8
mmol/mol
40.6
41.4
12.56
9882
59513
(3000475) Leukocytes [#/volume] in Synovial fluid
276
2101
0.78
3.75
1.6
1.6
e6/l
19470.2
15813.8
0.53
194
1556
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
216
977
1.33
3.74
1.3
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
76
713
0.64
3.67
1.2
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
76
713
0.64
3.67
1.2
1.7
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
25
62
2.42
3.66
1.0
1.3
—
—
—
0
0
(4094501)
315
2354
0.80
3.66
1.1
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
248
1901
0.78
3.58
1.1
1.2
u/ml
0.2
0.6
1.90
19
170
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
84
322
1.57
3.53
2.6
2.0
e6/l
535.2
676.4
1.22
41
137
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
577
2944
1.18
3.48
2.0
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
577
2944
1.18
3.48
2.0
1.4
g/l
7.4
7.4
0.31
417
2212
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
575
2933
1.18
3.48
2.0
1.4
g/l
4.0
4.0
0.07
403
2127
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
69
254
1.63
3.43
2.9
2.0
e9/l
0.3
0.2
0.37
63
228
(3037121) Protein [Mass/volume] in Urine
439
2189
1.21
3.42
2.8
2.9
g/l
0.3
0.4
0.62
213
981
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
832
4375
1.15
3.41
4.2
4.9
ng/l
106.9
109.3
0.25
716
3795
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
70
259
1.62
3.41
3.0
2.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
111
457
1.46
3.37
1.5
2.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
44
143
1.85
3.35
3.3
2.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2753
15460
1.08
3.32
1.8
1.7
pmol/l
23949798.8
33069350.4
0.45
2213
12734
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
78
299
1.57
3.30
1.2
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
78
299
1.57
3.30
1.2
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
80
309
1.56
3.28
1.6
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
80
309
1.56
3.28
1.6
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
55
537
0.61
3.22
1.3
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
11560
68204
1.08
3.20
5.3
5.6
mmol/l
2.6
2.5
5.52
10287
62964
(3038515) Glucose [Moles/volume] in Venous blood
362
1784
1.22
3.20
3.6
3.3
mmol/l
7.3
8.0
5.34
353
1747
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
537
2746
1.18
3.19
2.1
1.5
g/l
10.2
10.5
0.57
444
2326
(3008037) Lactate [Moles/volume] in Venous blood
379
1880
1.21
3.14
3.5
3.2
mmol/l
1.7
1.7
0.46
370
1837
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
30
341
0.53
3.09
1.1
2.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
52
184
1.70
3.03
2.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
90
364
1.49
3.03
3.8
4.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1114
7400
0.89
3.03
1.2
1.3
titre
427.4
468.6
0.35
190
1459
(3032352) Blasts [#/volume] in Cerebral spinal fluid
14
28
3.00
3.02
2.9
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
8876
54488
0.94
3.00
25.6
18.7
g/l
333.2
334.4
22.35
8810
53996
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
261
1255
1.25
2.92
1.4
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
75
668
0.67
2.91
1.1
1.1
iu/ml
3.5
1.8
—
7
25
(3024354) Oxygen [Partial pressure] in Venous blood
1144
6207
1.11
2.88
3.2
3.3
kpa
4.5
4.6
0.23
1115
5984
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1247
8209
0.90
2.87
1.2
1.2
u/ml
11.3
14.7
0.84
398
3029
(3051611) Lipemic interference index of Serum or Plasma
155
698
1.34
2.86
3.3
3.7
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
222
1050
1.27
2.86
2.7
2.4
mmol/l
4.1
4.1
0.44
216
1042
(3035285) Chloride [Moles/volume] in Venous blood
222
1050
1.27
2.86
2.7
2.4
mmol/l
105.9
105.8
0.08
216
1041
(3006462) Nitrate [Presence] in Urine
81
327
1.49
2.78
4.3
2.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
218
1034
1.27
2.76
2.7
2.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
31
335
0.55
2.73
1.5
2.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
65
252
1.55
2.69
2.3
2.7
%
27.5
38.8
2.75
22
89
(3024980) IgG subclass 4 [Mass/volume] in Serum
123
992
0.74
2.69
1.4
1.7
g/l
1.1
1.0
0.08
91
744
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
138
618
1.34
2.67
1.3
1.3
nmol/l
—
—
—
0
0
(4211845)
86
355
1.46
2.66
4.1
2.7
—
—
—
0
0
(1002224) Polysomnography panel
328
2352
0.83
2.64
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
66
589
0.67
2.62
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
543
2830
1.16
2.60
1.3
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
619
3257
1.15
2.60
2.1
1.5
g/l
1.2
1.1
0.35
546
2967
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
5399
31240
1.06
2.59
2.1
2.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
11293
66714
1.07
2.57
4.7
5.0
mmol/l
4.4
4.3
14.39
10121
61887
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
155
711
1.31
2.56
1.4
1.3
nmol/l
0.6
2.1
0.48
148
688
(3051101) Glucose [Moles/volume] in Cord blood
16
209
0.46
2.55
7.7
6.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
529
2758
1.16
2.53
2.1
1.5
g/l
3.1
3.0
1.37
408
2179
(3004451) EKG impression Narrative
94
399
1.42
2.53
1.3
1.3
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
9
14
3.86
2.52
1.7
1.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
61
548
0.67
2.52
1.0
1.1
u/ml
6.3
3.2
0.34
24
241
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
307
1530
1.21
2.51
1.5
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
155
714
1.31
2.50
1.4
1.3
nmol/l
0.1
0.2
0.73
14
62
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
307
1531
1.21
2.49
1.5
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
97
417
1.40
2.44
2.6
2.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
1052
5743
1.11
2.40
4.5
5.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
171
1296
0.79
2.38
1.4
1.4
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
16
40
2.40
2.38
6.5
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1458
8088
1.09
2.38
1.7
1.9
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
7
9
4.67
2.37
1.9
1.6
—
—
—
0
0
(3014891) Appearance of Pleural fluid
34
115
1.77
2.37
1.6
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
233
1705
0.82
2.36
1.5
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
207
999
1.25
2.33
4.6
4.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
43
406
0.63
2.28
1.1
2.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
97
423
1.38
2.27
3.4
3.8
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
76
641
0.71
2.27
1.2
1.1
au/ml
6.6
8.7
—
7
30
(4198724)
8
123
0.39
2.26
1.3
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
10864
64183
1.06
2.25
4.2
4.4
mmol/l
1.3
1.3
4.79
9568
58745
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
74
626
0.71
2.25
1.0
1.1
u/ml
0.6
1.4
1.32
28
262
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
438
2275
1.16
2.25
2.1
1.5
g/l
37.0
37.4
0.77
371
1966
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
112
501
1.34
2.25
1.1
1.2
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
6
7
5.14
2.23
11.2
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
988
5400
1.10
2.23
6.5
7.6
mmol/l
24.5
24.4
0.24
906
5068
(3014133) Dog dander IgE Ab [Units/volume] in Serum
42
396
0.64
2.22
1.0
1.1
u/ml
0.8
3.1
2.06
11
161
(3042733) HLA Ab [Presence] in Serum
31
314
0.59
2.22
5.3
5.3
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
8
13
3.69
2.21
1.8
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
344
2413
0.85
2.20
1.2
1.2
—
—
—
0
0
(3000492) Spirometry study
913
6010
0.91
2.16
1.4
1.5
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
9
130
0.41
2.15
2.0
2.4
—
137.9
—
0
17
(3051387) C reactive protein [Mass/volume] in Capillary blood
323
1644
1.18
2.15
3.3
3.4
mg/l
31.9
28.6
0.88
202
1099
(43055442) Apixaban [Mass/volume] in Serum or Plasma
34
119
1.72
2.15
1.8
1.7
ug/l
85.1
116.4
1.08
28
96
(3014271) Vancomycin [Susceptibility]
97
428
1.36
2.14
2.7
2.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
49
442
0.66
2.12
1.7
2.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
11184
66165
1.06
2.11
4.7
4.9
mmol/l
1.3
1.3
25.34
9946
60924
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2367
13439
1.07
2.10
1.6
1.8
mg/l
1.7
1.3
3.08
1854
10573
(3023383) Lactate [Moles/volume] in Pleural fluid
54
214
1.52
2.10
1.2
1.4
mmol/l
3.8
3.7
0.02
46
192
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
86
700
0.74
2.09
1.0
1.0
ng/l
36.0
41.2
0.75
64
475
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
86
700
0.74
2.09
1.0
1.0
ng/l
687.3
727.1
0.45
63
470
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
425
2218
1.15
2.07
2.2
1.5
g/l
0.1
0.0
0.95
390
2020
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
19
55
2.07
2.07
1.6
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
1390
7745
1.08
2.07
1.4
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
22
239
0.55
2.06
7.8
7.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
62
531
0.70
2.05
1.0
1.1
u/ml
0.6
1.0
0.37
22
201
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
86
698
0.74
2.05
1.0
1.0
ng/l
275.2
305.1
0.65
66
484
(3023430) Cat dander IgE Ab [Units/volume] in Serum
39
366
0.64
2.05
1.0
1.1
u/ml
0.2
2.6
—
10
138
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
238
1709
0.83
2.03
1.7
1.8
mg/l
10.7
11.4
0.73
215
1598
(3004775) Volume in Urine collected for unspecified duration
107
840
0.76
2.03
2.0
2.3
ml
704.0
695.2
0.07
58
563
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
21
64
1.97
2.02
3.6
1.6
u/l
42.7
53.7
—
6
26
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
54
217
1.49
1.99
1.3
1.3
ug/l
125.3
34.3
0.55
26
93
(3035933) Granulocytes/100 leukocytes in Blood
26
86
1.81
1.99
1.5
1.3
—
—
—
0
0
(4010399)
789
5207
0.90
1.99
1.5
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1285
7151
1.09
1.98
2.7
3.1
ng/l
243.1
254.8
0.33
1168
6582
(3008898) HLA-B27 [Presence]
169
1250
0.81
1.96
1.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
39
146
1.60
1.95
1.1
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
68
567
0.72
1.94
1.1
1.2
titre
78.1
146.0
1.31
16
95
(3003181) Sodium [Moles/volume] in Urine
216
1072
1.21
1.93
1.3
1.4
mmol/l
61.4
66.1
0.98
176
850
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
204
1476
0.83
1.91
1.3
1.3
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
6
5.00
1.89
1.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
28
277
0.61
1.87
1.1
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
26
88
1.77
1.86
2.2
2.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
985
5436
1.09
1.86
2.1
2.4
ug/g
151.7
172.9
0.81
758
4346
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
20
62
1.94
1.85
1.0
1.1
iu/ml
5.7
17.0
—
7
22
(3026389) Candida sp identified in Specimen by Organism specific culture
120
560
1.29
1.85
1.4
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
26
89
1.75
1.80
2.2
2.2
—
—
—
0
0
(3019977) pH of Arterial blood
111
515
1.29
1.80
2.4
2.3
ph
7.4
7.4
0.34
43
178
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
10
23
2.61
1.76
1.2
1.7
u/field
1.6
0.8
—
5
13
(3047189) Immunofixation for 24 hour Urine
70
304
1.38
1.76
2.0
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
54
458
0.71
1.74
1.0
1.1
u/ml
1.3
1.6
—
10
98
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
34
315
0.65
1.73
1.0
1.0
u/ml
0.3
0.3
—
9
83
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
131
980
0.80
1.73
1.4
1.4
pmol/l
52.5
107.9
1.00
70
285
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
399
2712
0.88
1.72
1.6
1.8
u/l
37.8
37.6
0.05
338
2311
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
391
2062
1.14
1.70
2.2
1.5
g/l
0.0
0.0
0.80
357
1868
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
44
176
1.50
1.70
1.4
1.4
%
17.4
27.6
1.54
34
143
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
384
2025
1.14
1.68
2.2
1.5
g/l
0.0
0.0
0.00
354
1862
(3035880) pH of Pleural fluid
94
431
1.31
1.68
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
186
1338
0.83
1.68
1.5
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
197
1408
0.84
1.66
1.3
1.3
e6/l
46.9
18.7
0.38
142
1098
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
135
652
1.24
1.61
1.4
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
198
1410
0.84
1.61
1.4
1.4
e6/l
536.3
1494.2
1.42
152
1165
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
344
1807
1.15
1.61
1.8
2.2
%
88.5
85.1
2.24
328
1708
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
162
1174
0.83
1.60
1.1
1.1
u/ml
3.6
9.8
1.44
13
108
(3032057) Clostridioides difficile [Presence] in Stool
33
126
1.57
1.57
1.6
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
235
1202
1.18
1.57
1.2
1.2
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
29
0.00
1.55
0.0
1.1
—
0.2
—
0
7
(3009871) Measles virus Ab [Titer] in Serum
17
181
0.56
1.55
1.9
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
359
2432
0.88
1.51
1.4
1.4
—
—
—
0
0
(4062490)
79
616
0.77
1.51
1.3
1.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
79
616
0.77
1.51
1.3
1.4
g/l
7.0
7.0
0.01
48
424
(3038071) Oxygen [Partial pressure] in Mixed venous blood
32
290
0.66
1.51
8.1
7.8
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
79
615
0.77
1.49
1.3
1.4
g/l
0.5
0.5
0.38
51
428
(3028192) IgG subclass 2 [Mass/volume] in Serum
79
615
0.77
1.49
1.3
1.4
g/l
3.4
3.2
0.51
50
426
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
269
1398
1.16
1.48
2.2
1.2
u/l
39.8
23.6
1.14
228
1199
(3013166) Neutrophils/100 leukocytes in Synovial fluid
34
303
0.67
1.48
1.2
1.3
%
65.0
60.7
0.31
29
265
(3012565) Volume of 24 hour Urine
77
351
1.32
1.47
2.2
2.1
ml
1935.6
2036.0
0.33
62
301
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
84
647
0.78
1.47
1.1
1.1
—
—
—
0
0
(3036603) Volume of Urine
87
404
1.29
1.46
2.2
1.4
ml
2150.0
2021.1
0.21
31
91
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
7343
43206
1.04
1.45
3.0
2.9
pmol/l
15.0
14.9
1.56
6377
38360
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
23
222
0.62
1.45
1.1
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
45
188
1.44
1.45
1.3
1.1
u/l
3.4
2.2
0.19
11
24
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
17
55
1.85
1.44
1.4
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
17
55
1.85
1.44
1.4
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
17
55
1.85
1.44
1.4
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
118
871
0.81
1.43
1.3
1.3
e6/l
162977.1
146943.7
0.10
83
618
(3001893) Eosinophils/100 leukocytes in Pleural fluid
55
239
1.38
1.43
1.3
1.4
%
2.2
2.8
0.25
45
190
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
23
2.35
1.41
1.0
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
399
2670
0.89
1.39
4.6
4.9
mmol/l
3.9
4.0
0.86
371
2499
(3037692) Legionella sp identified in Specimen by Organism specific culture
53
231
1.38
1.37
1.2
1.7
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
62
491
0.76
1.36
1.2
1.3
nmol/l
1.3
1.3
0.16
50
358
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1086
6939
0.93
1.35
1.5
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2585
14908
1.05
1.34
3.9
4.2
ng/l
791.8
830.7
0.04
2227
12905
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
182
1280
0.85
1.33
1.3
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
24
224
0.64
1.33
1.1
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
48
1.87
1.32
3.7
1.2
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
62
279
1.33
1.32
1.4
1.4
%
65.1
65.4
0.03
48
219
(3045716) Anion gap in Serum or Plasma
53
427
0.74
1.32
1.8
2.2
mmol/l
9.5
9.1
0.35
45
310
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
245
1681
0.87
1.30
1.5
1.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
402
2675
0.90
1.29
1.6
1.6
titre
112.9
275.1
2.62
14
108
(4024509)
106
514
1.24
1.28
1.6
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
140
1003
0.84
1.28
1.2
1.2
—
—
—
0
0
(44806118)
146
732
1.20
1.28
1.2
1.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
344
1841
1.12
1.27
1.9
2.4
g/l
3.8
3.6
0.72
324
1758
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
29
114
1.53
1.27
1.4
1.4
%
9.6
7.8
0.25
15
48
(44790048)
146
733
1.20
1.26
1.2
1.6
—
—
—
0
0
(44790049)
146
733
1.20
1.26
1.2
1.6
—
—
—
0
0
(44790047)
146
733
1.20
1.26
1.2
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
136
975
0.83
1.26
1.1
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
178
1247
0.85
1.26
1.2
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
697
3867
1.08
1.25
2.8
2.9
%
1.2
1.3
0.46
689
3849
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
249
1699
0.88
1.23
1.2
1.4
g/l
0.2
0.2
0.48
236
1616
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
152
769
1.19
1.22
3.2
3.8
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
303
1614
1.13
1.22
2.2
2.5
%
209.8
200.0
1.06
289
1529
(3021387) Prolactin [Units/volume] in Serum or Plasma
150
1062
0.85
1.22
1.7
1.8
mu/l
262.9
257.4
0.12
144
992
(44786800) Granulocytes/100 leukocytes in Body fluid
25
96
1.56
1.21
1.3
1.3
%
22.1
28.2
0.36
16
65
(3000060) B lymphocytes [#/volume] in Blood
19
68
1.68
1.20
1.9
1.9
e6/l
17948.6
117.3
—
7
37
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
95
460
1.24
1.19
1.3
1.2
mmol/l
2.2
2.2
0.13
89
428
(40763590) HLA-DQ beta [Type]
5
11
2.73
1.18
1.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
176
1225
0.86
1.17
1.4
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
40
329
0.73
1.17
8.4
7.8
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
11
33
2.00
1.16
3.9
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
677
3767
1.08
1.16
2.8
2.9
%
0.6
0.7
1.04
641
3609
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
22
83
1.59
1.15
3.4
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
66
307
1.29
1.15
1.7
1.3
iu/l
11.6
10.3
0.31
53
247
(3016750) Collection duration of Urine
77
578
0.80
1.15
2.0
2.1
min
509.8
498.7
0.54
45
429
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
65
497
0.78
1.14
1.1
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
26
103
1.51
1.12
1.4
1.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
910
5126
1.07
1.12
3.5
3.5
g/l
127.1
132.5
9.24
887
5005
(3009445) Proteinase 3 Ab [Units/volume] in Serum
529
3443
0.92
1.11
1.6
1.5
u/ml
20.5
17.3
0.12
14
83
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
23
89
1.55
1.10
1.3
1.4
u/l
32.0
42.3
0.33
16
65
(3017817) Protein [Mass] in Urine collected for unspecified duration
113
811
0.83
1.10
2.5
2.2
—
0.4
—
0
7
(40760409) HLA-A [Type] by High resolution
5
12
2.50
1.08
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
5
12
2.50
1.08
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
5
12
2.50
1.08
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
5
12
2.50
1.08
1.0
1.0
—
—
—
0
0
(3020891) Body temperature
525
3412
0.92
1.07
5.0
5.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
32
134
1.43
1.07
1.2
1.3
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
31
129
1.44
1.07
1.4
1.2
mu/l
54.6
67.0
0.20
24
89
(4306422)
115
821
0.84
1.06
1.2
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
41
330
0.74
1.06
1.9
1.7
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
112
560
1.20
1.06
1.3
1.4
mosm/kgh2o
279.6
280.5
0.11
84
425
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
24
95
1.52
1.05
1.1
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
266
1423
1.12
1.04
1.3
1.2
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
28
115
1.46
1.04
2.1
1.9
%
8.7
9.2
0.07
23
101
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
12
123
0.58
1.02
1.3
1.7
—
88.7
—
0
12
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
38
166
1.37
1.02
1.1
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
9
97
0.56
1.02
1.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
7
20
2.10
1.02
1.4
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
37
300
0.74
1.02
1.1
1.1
ratio
1.1
1.1
0.17
12
89
(36660697) Celiac disease serology panel - Serum
559
3612
0.93
1.01
1.1
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
260
1742
0.89
1.01
1.2
1.4
g/l
1.2
1.2
0.07
249
1658
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
53
245
1.30
1.00
2.5
2.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
20
178
0.67
0.95
1.1
1.1
—
—
—
0
0
(3020618) Glucose [Moles/volume] in Synovial fluid
11
36
1.83
0.94
1.0
1.1
mmol/l
5.9
6.0
0.04
11
24
(3034891) Synovial lining cells/100 cells in Synovial fluid
77
377
1.23
0.93
1.5
1.4
%
3.7
4.1
0.14
18
93
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
20
177
0.68
0.93
1.1
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
40
315
0.76
0.92
1.4
1.4
—
—
—
0
0
(3036489) Thrombin time
417
2303
1.09
0.91
1.8
2.0
s
21.9
22.0
0.07
376
2047
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
28
232
0.72
0.90
1.0
1.1
u/ml
—
9.1
—
0
16
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
21
84
1.50
0.90
1.0
1.1
—
—
—
0
0
(44813793)
42
327
0.77
0.90
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
223
1494
0.89
0.89
1.6
1.3
u/l
7.8
6.4
1.43
174
1206
(3017461) Flecainide [Moles/volume] in Serum or Plasma
13
46
1.70
0.89
1.5
1.5
umol/l
0.7
0.6
—
6
40
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
11
37
1.78
0.88
1.2
1.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
18
70
1.54
0.87
1.1
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
30
130
1.38
0.87
1.1
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
71
518
0.82
0.87
1.1
1.2
mmol/l
10.9
12.3
0.79
22
186
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
22
90
1.47
0.86
3.1
2.5
u/field
0.2
0.2
0.11
22
90
(3040151) Glucose [Moles/volume] in Capillary blood
186
989
1.13
0.85
5.9
14.5
mmol/l
7.1
7.7
1.99
158
803
(3024932) HLA-DR beta [Type]
35
277
0.76
0.85
1.1
1.0
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
134
697
1.15
0.85
1.7
1.9
g/24h
0.4
1.2
—
5
37
(3006576) Bicarbonate [Moles/volume] in Blood
59
437
0.81
0.84
8.0
6.6
mmol/l
25.4
25.2
0.20
51
396
(3017569) Oxygen content in Arterial blood
84
420
1.20
0.84
2.0
2.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
190
1278
0.89
0.83
1.4
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
104
729
0.85
0.83
1.5
2.1
titre
768.0
3690.0
—
5
40
(3000570) Elastase.pancreatic [Mass/mass] in Stool
304
1664
1.10
0.83
1.4
1.5
ug/g
256.7
265.6
0.29
182
1012
(4212803)
5
59
0.51
0.81
1.2
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
60
0.50
0.81
1.6
1.7
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
17
0.00
0.81
0.0
6.0
—
0.3
—
0
17
(3042951) Complement C1q Ab [Units/volume] in Serum
0
17
0.00
0.81
0.0
1.2
—
22.0
—
0
5
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
46
348
0.79
0.80
1.3
1.2
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
6
19
1.89
0.80
1.0
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
77
0.54
0.80
1.9
2.0
umol/l
14.5
16.8
—
7
77
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
685
3877
1.06
0.80
4.4
4.1
%
46.8
48.0
0.63
676
3827
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
21
87
1.45
0.79
1.2
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
5
13
2.31
0.78
1.2
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
36
279
0.77
0.77
1.0
1.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
735
4177
1.06
0.76
3.8
3.5
mmol/l
25.0
25.0
0.20
709
4048
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
108
748
0.86
0.76
1.2
1.1
mmol/l
7.4
7.6
0.28
82
519
(3036525) Urea [Moles/time] in 24 hour Urine
16
63
1.52
0.75
2.8
3.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1556
9008
1.04
0.75
1.5
1.3
g/l
2.8
3.0
4.41
933
5395
(3044242) Glucose [Moles/volume] in Arterial blood
83
421
1.18
0.74
1.7
1.7
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
103
714
0.86
0.74
1.2
1.4
promille
1.2
1.5
0.95
87
547
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
161
859
1.13
0.73
1.1
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
13
49
1.59
0.73
1.2
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
135
713
1.14
0.72
1.1
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
337
2183
0.92
0.72
1.4
1.5
iu/ml
7.3
9.8
—
7
49
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
91
467
1.17
0.72
1.1
1.2
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
5
15
2.00
0.72
1.8
1.1
nmol/l
1121.5
537.5
—
5
15
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
20
84
1.43
0.71
1.3
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
32
146
1.32
0.71
1.2
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
93
647
0.86
0.71
1.1
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
116
794
0.88
0.71
1.1
1.2
%
110.8
109.5
0.17
100
716
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
41
308
0.80
0.70
2.0
2.4
umol/l
52.7
56.0
0.43
30
254
(3026692) Albumin [Mass/volume] in Peritoneal fluid
27
214
0.76
0.70
1.2
1.7
g/l
12.6
13.3
0.15
19
161
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
90
626
0.86
0.69
1.1
1.2
%
91.3
96.9
1.17
79
582
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
31
142
1.31
0.68
11.1
11.1
mmol/l
5.4
5.6
0.16
31
142
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
179
967
1.11
0.67
1.3
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
85
592
0.86
0.67
1.2
1.2
miu/ml
166.8
192.4
0.21
17
136
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
10
36
1.67
0.66
1.3
1.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
53
261
1.22
0.66
1.8
1.6
mmol/l
0.3
0.3
0.00
48
248
(4268621)
77
539
0.86
0.65
2.2
2.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1614
9983
0.97
0.64
1.2
1.2
u/ml
1.8
2.2
0.42
393
2665
(3020650) Glucose [Presence] in Urine
33
154
1.29
0.64
1.4
1.3
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
248
1617
0.92
0.64
1.3
1.3
mg/l
611.7
583.8
0.28
232
1541
(3006270) Folate [Moles/volume] in Blood
116
614
1.13
0.63
1.2
1.2
nmol/l
335.5
328.2
0.15
88
494
(3007919) Fasciola sp Ab [Titer] in Serum
0
12
0.00
0.63
0.0
1.2
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
13
0.00
0.62
0.0
1.0
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
43
316
0.82
0.62
27.2
36.4
ug/l
7.2
7.4
0.41
35
290
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1553
9602
0.97
0.61
7.8
7.5
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
14
0.00
0.61
0.0
1.1
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
0
14
0.00
0.61
0.0
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
32
150
1.28
0.61
1.3
1.2
pmol/l
280.4
270.0
0.06
21
110
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
217
1418
0.92
0.60
1.2
1.2
mmol/l
3.8
4.0
1.92
201
1340
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
11
42
1.57
0.60
1.1
1.1
umol/24h
1.8
2.1
0.41
11
42
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
319
1782
1.08
0.60
2.9
2.8
mg/l
1.9
1.8
0.74
282
1580
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
14
57
1.47
0.59
1.1
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
148
799
1.11
0.59
1.9
1.3
pmol/l
236.6
246.4
0.22
108
576
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
34
162
1.26
0.58
1.9
2.8
mmol/l
6.9
8.4
2.04
22
94
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
53
0.57
0.58
1.0
1.1
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
5
54
0.56
0.58
1.0
1.2
nmol/l
0.1
0.1
—
5
40
(3024928) Oxygen saturation in Venous blood
320
1791
1.07
0.58
2.7
3.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
36
173
1.25
0.58
1.1
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
24
187
0.77
0.58
2.0
2.4
ug/l
2.9
3.1
—
9
59
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
29
220
0.79
0.57
1.1
1.1
%
97.0
100.8
0.20
22
176
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
32
152
1.26
0.56
1.1
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
84
439
1.15
0.56
1.4
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
192
1055
1.09
0.55
1.6
1.5
%
61.6
62.6
0.11
127
704
(3044007) Cell count panel - Peritoneal fluid
29
219
0.79
0.55
1.6
2.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
58
408
0.85
0.55
1.1
1.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
23
178
0.77
0.54
1.2
1.3
g/l
0.3
0.3
0.57
17
143
(3028679) Herpes simplex virus Ab [Presence] in Serum
32
237
0.81
0.52
1.1
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
131
869
0.90
0.52
1.1
1.1
g/l
1.5
1.6
0.20
119
782
(3007566) Smooth muscle Ab [Titer] in Serum
239
1543
0.93
0.52
1.2
1.2
titre
123.5
108.7
0.10
23
141
(3018405) Lactate [Moles/volume] in Arterial blood
489
3085
0.95
0.52
4.1
4.5
mmol/l
1.4
1.4
0.68
474
3025
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
55
280
1.18
0.52
2.3
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
55
280
1.18
0.52
2.3
2.4
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
57
399
0.86
0.52
1.7
1.3
u/l
8.4
6.1
0.41
49
344
(21494890) Protein electrophoresis panel - 24 hour Urine
149
813
1.10
0.51
2.2
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
310
1980
0.94
0.51
1.1
1.1
titre
179.4
253.2
—
9
56
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
62
320
1.16
0.51
1.3
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
382
2164
1.06
0.51
3.2
3.1
pmol/l
4.5
4.4
0.30
339
1933
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
7
26
1.61
0.50
1.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
43
215
1.20
0.50
1.3
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
55
384
0.86
0.49
1.1
1.1
nmol/l
5.4
7.1
0.26
14
81
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
69
361
1.15
0.48
1.0
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
71
485
0.88
0.48
2.2
2.2
ug/min
64.4
171.1
1.36
23
132
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
40
286
0.84
0.48
3.5
5.6
%
72.3
71.5
0.07
33
245
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
53
272
1.17
0.47
1.1
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
13
107
0.73
0.47
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
51
356
0.86
0.46
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
51
356
0.86
0.46
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
62
323
1.15
0.46
1.3
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
125
824
0.91
0.46
1.2
1.3
u/ml
3.5
4.2
0.30
54
401
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
36
179
1.21
0.45
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
51
355
0.86
0.45
1.1
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
18
82
1.32
0.44
1.6
1.6
umol/l
37.9
44.2
0.55
18
82
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
191
1233
0.93
0.44
1.1
1.2
u/ml
3.6
8.1
—
9
127
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
18
139
0.78
0.43
1.2
1.8
mmol/l
1.2
1.2
0.65
18
134
(3051593) INR in Capillary blood by Coagulation assay
87
467
1.12
0.43
12.9
10.2
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
10
0.00
0.43
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
52
359
0.87
0.42
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
52
359
0.87
0.42
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
40
203
1.18
0.42
1.2
1.1
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
0
11
0.00
0.42
0.0
1.0
—
0.2
—
0
11
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
11
0.00
0.42
0.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
84
0.71
0.41
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
52
358
0.87
0.41
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
194
1085
1.07
0.41
1.5
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
68
361
1.13
0.41
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
80
535
0.90
0.41
1.0
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
154
854
1.08
0.41
1.8
1.3
mu/l
82.0
73.4
0.16
134
757
(3023183) Ammonium ion [Moles/volume] in Plasma
293
1855
0.95
0.40
2.1
2.8
umol/l
30.4
34.0
2.09
235
1579
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
54
369
0.88
0.39
1.1
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
131
852
0.92
0.39
1.2
1.3
u/ml
4.7
4.2
0.11
51
312
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
64
340
1.13
0.39
1.1
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
9
40
1.35
0.38
2.2
2.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
195
1248
0.94
0.38
1.1
1.2
u/ml
3.4
8.1
1.78
14
189
(4027681)
36
253
0.85
0.38
1.3
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
73
488
0.90
0.38
1.7
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
562
3497
0.96
0.38
1.2
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
238
1512
0.94
0.37
1.6
1.7
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
16
74
1.30
0.37
1.2
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
3131
18520
1.02
0.37
1.7
1.7
mmol/l
1.3
1.4
1.68
2472
15182
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
29
145
1.20
0.37
1.5
1.2
u/l
8.7
11.8
0.63
24
96
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
49
0.61
0.36
1.0
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
20
96
1.25
0.36
1.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
55
372
0.89
0.35
2.0
2.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
31
219
0.85
0.35
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
95
623
0.91
0.35
1.5
1.4
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
6
26
1.38
0.35
2.3
1.5
%
0.8
1.8
—
6
26
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
845
4927
1.03
0.35
1.6
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
88
579
0.91
0.35
1.5
1.4
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
13
101
0.77
0.34
1.2
1.4
%
75.2
71.9
0.63
13
96
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
16
75
1.28
0.34
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
154
862
1.07
0.34
1.2
1.2
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
13
59
1.32
0.34
1.1
1.1
u/l
14.9
8.5
0.57
13
59
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
15
114
0.79
0.34
1.2
1.2
%
47.5
50.2
—
6
39
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
6
27
1.33
0.34
1.0
1.0
nmol/l
250.2
233.8
—
6
27
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
32
224
0.86
0.33
1.1
1.3
nmol/l
214.6
146.5
0.59
24
168
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
11
87
0.76
0.33
1.2
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
71
385
1.11
0.32
1.1
1.1
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
13
100
0.78
0.32
1.2
1.4
mu/l
376.1
941.2
0.80
13
95
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
37
255
0.87
0.32
1.0
1.1
u/l
1.0
1.0
0.08
18
124
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
25
178
0.84
0.32
1.1
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
98
541
1.09
0.32
1.5
1.7
umol/l
77.1
76.7
—
7
29
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
27
190
0.85
0.31
1.1
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
127
816
0.93
0.30
1.1
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
25
126
1.19
0.30
1.2
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
25
126
1.19
0.30
2.0
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
82
450
1.09
0.30
1.0
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
509
3154
0.97
0.30
2.3
2.4
ug/l
582.2
614.7
0.09
492
3000
(3033923) Metanephrine [Moles/time] in 24 hour Urine
19
93
1.23
0.30
1.2
1.1
umol/24h
0.8
0.7
0.18
11
42
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
112
0.80
0.30
6.1
4.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
22
157
0.84
0.29
1.0
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
96
532
1.08
0.29
1.3
2.0
mmol/l
7.3
7.3
0.02
69
361
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
14
105
0.80
0.29
1.7
1.8
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
16
77
1.25
0.29
1.1
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
66
435
0.91
0.29
2.6
3.6
%
13.2
13.3
0.28
66
429
(3023419) Bacteria identified in Sputum by Culture
182
1033
1.06
0.29
2.3
2.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
21
150
0.84
0.28
1.1
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
9
71
0.76
0.28
1.1
1.1
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
21
105
1.20
0.28
1.3
1.3
mmol/l
1.0
0.9
0.01
15
66
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
10
45
1.33
0.28
4.3
3.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
153
866
1.06
0.27
1.1
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
20
100
1.20
0.27
1.0
1.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
44
0.68
0.27
1.4
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
78
1.23
0.27
1.1
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
136
768
1.06
0.26
3.2
3.0
mg/l
38.3
54.0
0.54
103
585
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
11
51
1.29
0.26
1.1
1.3
%
1.3
1.3
0.13
11
51
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
65
357
1.09
0.25
2.3
2.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
241
1507
0.96
0.25
1.5
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
6
50
0.72
0.25
1.0
1.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
37
197
1.13
0.25
1.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
6
52
0.69
0.24
1.3
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
32
169
1.14
0.24
1.1
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
605
3539
1.03
0.24
1.3
1.3
au/ml
63.1
50.3
0.57
34
160
(3034092) Cytoplasmic Ig cells/100 cells in Blood
10
76
0.79
0.24
7.8
10.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
171
1076
0.95
0.23
1.1
1.2
u/ml
1.1
7.1
—
7
89
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
34
229
0.89
0.23
1.4
2.4
e6/l
13486.8
6108.7
0.27
22
124
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
23
1.30
0.23
1.4
1.0
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
61
336
1.09
0.23
1.1
6.2
mg/l
56.5
2324.3
1.34
44
249
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
57
372
0.92
0.22
1.4
1.3
g/l
1.3
1.5
—
5
30
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
40
216
1.11
0.22
1.2
1.0
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
6
0.00
0.22
0.0
1.2
—
134.1
—
0
6
(3001488) Cow milk IgE Ab [Units/volume] in Serum
0
6
0.00
0.22
0.0
1.0
—
—
—
0
0
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
6
0.00
0.22
0.0
3.3
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.22
0.0
1.3
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
6
0.00
0.22
0.0
1.0
—
—
—
0
0
(3012403) Metanephrines [Moles/time] in 24 hour Urine
0
6
0.00
0.22
0.0
1.0
—
—
—
0
0
(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
0.22
0.0
1.1
—
70.7
—
0
7
(3040794) Aluminum [Moles/volume] in Urine
0
7
0.00
0.22
0.0
1.3
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(3025315) Body weight
16
80
1.20
0.22
4.5
4.8
—
—
—
0
0
(44806420)
42
278
0.91
0.22
2.5
2.3
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
8
62
0.77
0.22
1.5
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
32
215
0.89
0.21
1.1
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
157
987
0.95
0.21
1.5
1.6
u/ml
107.9
115.4
0.45
38
222
(3001218) Citrate [Mass/time] in 24 hour Urine
0
8
0.00
0.21
0.0
1.5
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
8
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.21
0.0
2.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
90
506
1.07
0.21
1.1
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
42
228
1.11
0.21
1.6
1.4
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
40
265
0.90
0.21
1.4
2.4
e6/l
1091.5
2570.3
0.39
32
191
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
270
1564
1.04
0.21
1.6
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
90
507
1.06
0.20
1.1
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
9
69
0.78
0.20
1.1
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
11
53
1.24
0.20
1.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
54
351
0.92
0.20
1.5
1.5
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
6
30
1.20
0.20
1.3
1.3
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
31
1.16
0.19
1.0
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
144
825
1.05
0.19
1.5
1.4
%
26.9
24.7
0.32
90
556
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
55
356
0.93
0.19
1.5
1.4
u/ml
3.4
1.4
0.50
30
213
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
91
578
0.94
0.19
1.7
1.6
u/ml
38.3
28.5
0.66
17
129
(3036670) Protein [Mass/volume] in Synovial fluid
52
288
1.08
0.19
1.1
1.3
g/l
42.1
41.2
0.16
26
158
(3016018) Differential panel - Cerebral spinal fluid
112
639
1.05
0.18
1.3
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
7
36
1.17
0.18
1.1
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
145
833
1.04
0.18
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
244
1417
1.03
0.18
1.2
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
11
54
1.22
0.18
1.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
26
139
1.12
0.17
1.2
2.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
297
1832
0.97
0.17
1.7
1.6
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
41
0.73
0.17
1.0
1.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
8
40
1.20
0.17
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
27
180
0.90
0.17
1.0
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
190
1180
0.97
0.17
1.1
1.2
—
12.5
—
0
14
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
327
2010
0.98
0.16
1.1
1.1
iu/ml
116.1
105.9
0.19
100
699
(43055514) Macroprolactin [Presence] in Serum or Plasma
10
72
0.83
0.15
1.2
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
100
628
0.95
0.15
1.3
1.3
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
73
414
1.06
0.15
1.1
1.2
mmol/l
36.7
34.0
0.54
57
352
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
34
222
0.92
0.15
1.5
1.3
%
39.1
35.0
0.23
27
142
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
14
97
0.87
0.15
1.6
2.9
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
72
456
0.95
0.15
1.0
1.1
mg/l
281.3
275.2
0.34
65
416
(3017143) Hepatitis C virus Ab [Presence] in Serum
828
4896
1.02
0.15
1.6
1.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
31
203
0.92
0.14
1.2
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
158
916
1.03
0.14
1.3
1.3
u/ml
277.3
292.3
0.28
98
602
(42529406) Shigella sp [Presence] in Stool by Culture
259
1514
1.03
0.14
1.2
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
131
758
1.04
0.13
1.2
1.3
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
48
270
1.07
0.13
1.1
1.1
ng/l
538.1
669.0
0.12
15
70
(3014765) Yersinia sp identified in Stool by Organism specific culture
258
1511
1.02
0.13
1.2
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
25
164
0.91
0.12
1.3
1.5
ug/l
11.6
9.6
0.81
25
164
(3013637) Mi-2 Ab [Presence] in Serum
31
201
0.92
0.12
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
31
201
0.92
0.12
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
31
201
0.92
0.12
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
31
201
0.92
0.12
1.2
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
3916
23374
1.01
0.12
2.2
2.3
u/l
242.7
270.7
1.02
3667
21937
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
79
453
1.05
0.12
1.2
1.3
titre
82.0
94.2
—
5
40
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
51
323
0.95
0.11
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
256
1503
1.02
0.11
1.2
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
16
107
0.90
0.11
1.1
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
3711
22158
1.01
0.11
3.2
3.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
503
2975
1.01
0.10
1.3
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
37
236
0.94
0.10
1.2
1.4
nmol/l
0.1
0.1
0.10
26
195
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
26
1.15
0.10
1.4
1.3
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
26
1.15
0.10
1.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
40
254
0.94
0.10
1.5
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
485
2870
1.01
0.10
2.1
1.7
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
28
1.07
0.09
1.0
1.0
—
—
—
0
0
(44806071)
11
75
0.88
0.09
1.1
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
19
104
1.10
0.09
1.3
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
17
112
0.91
0.09
1.1
1.2
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
6
32
1.12
0.09
1.0
1.2
u/l
200.5
233.0
—
6
27
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
10
52
1.15
0.09
1.1
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
3582
21400
1.01
0.09
2.9
2.8
umol/l
5904.7
5489.8
0.17
3001
18473
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
83
481
1.04
0.09
2.4
2.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
34
1.06
0.08
1.2
1.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
36
228
0.95
0.08
1.1
1.0
iu/ml
23.0
10.0
—
7
56
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
154
903
1.02
0.08
1.5
1.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
30
169
1.06
0.08
1.1
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
22
142
0.93
0.08
1.2
1.3
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
16
105
0.91
0.08
1.4
1.4
%
83.0
84.9
—
7
51
(3044290) Cell count panel - Cerebral spinal fluid
206
1258
0.98
0.08
1.3
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
107
659
0.97
0.08
1.8
2.0
ug/l
4.2
3.5
0.27
88
583
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
25
160
0.94
0.07
1.6
1.8
ng/l
116.6
148.5
0.66
25
160
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
8
46
1.04
0.07
1.1
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
12
80
0.90
0.07
3.1
2.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
28
178
0.94
0.07
3.0
2.9
—
—
—
0
0
(4015189)
39
245
0.95
0.07
2.5
2.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
9
52
1.04
0.07
1.1
1.3
umol/24h
383.1
357.2
—
9
52
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
9
61
0.88
0.06
1.6
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
25
159
0.94
0.06
1.5
1.9
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
260
1580
0.99
0.06
2.9
2.8
nmol/l
0.8
0.8
0.03
187
1200
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
137
806
1.02
0.06
1.4
1.6
iu/l
4.4
16.8
0.48
34
246
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
18
116
0.93
0.06
1.9
1.1
%
66.3
81.1
—
8
69
(3034274) Bile acid [Moles/volume] in Serum --fasting
30
171
1.05
0.06
1.0
1.2
umol/l
11.6
11.9
0.03
23
122
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
902
5440
0.99
0.05
1.2
1.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
69
425
0.97
0.05
1.3
1.4
umol/l
14.5
15.2
0.37
63
394
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
24
152
0.95
0.05
1.5
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
30
188
0.96
0.05
1.2
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
661
3941
1.01
0.04
2.4
2.4
au/ml
42.0
24.8
0.78
19
137
(3025577) Chromium [Mass/volume] in Blood
105
641
0.98
0.04
1.9
2.0
ug/l
2.4
1.9
0.43
84
535
(3015183) Erythrocyte sedimentation rate
37
214
1.04
0.04
1.5
1.2
—
—
—
0
0
(4146454)
176
1068
0.99
0.04
2.6
2.8
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
29
167
1.04
0.04
1.1
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
16
102
0.94
0.03
1.1
1.3
%
77.1
74.9
—
7
47
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
53
310
1.03
0.03
1.1
1.2
—
—
—
0
0
(4133840)
36
223
0.97
0.03
1.2
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
84
495
1.02
0.03
1.0
1.1
u/ml
3.3
3.8
0.11
27
188
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
19
108
1.06
0.03
1.1
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
52
319
0.98
0.03
1.0
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
55
1.09
0.03
1.1
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
116
704
0.99
0.02
1.2
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
12
77
0.93
0.02
1.1
1.1
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
12
77
0.93
0.02
1.8
1.4
ml/s/173m2
0.8
0.9
—
7
54
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
17
97
1.05
0.02
1.0
1.2
—
—
—
0
0
(4281824)
31
191
0.97
0.02
1.1
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
29
169
1.03
0.01
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
314
1891
1.00
0.01
1.2
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
12
76
0.95
0.01
1.2
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
80
475
1.01
0.01
1.2
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
18
112
0.96
0.01
1.2
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1035
6214
1.00
0.01
1.5
1.6
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
46
272
1.01
0.00
1.4
1.6
umol/l
62.3
93.0
0.80
20
131
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
13
78
1.00
0.00
1.1
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
13
76
1.03
0.00
1.2
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
15
93
0.97
0.00
1.1
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
22
130
1.01
0.00
1.3
1.2
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
21
123
1.02
0.00
1.5
1.2
titre
269.2
154.9
—
5
9
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
56
333
1.01
0.00
1.1
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
13
80
0.97
0.00
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
51
305
1.00
0.00
1.1
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
14
81
1.04
0.00
1.1
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
29
175
0.99
0.00
1.2
1.4
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
11
64
1.03
0.00
1.2
1.0
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
20
119
1.01
0.00
1.2
1.1
%
81.7
81.5
—
10
71
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
20
118
1.02
0.00
1.3
1.2
ng/l
5861.7
145.8
—
10
84
(3033799) Differential panel - Peritoneal fluid
38
226
1.01
0.00
1.4
2.4
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
48
290
0.99
0.00
1.2
1.2
%
81.5
50.7
—
6
22
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
10
59
1.02
0.00
1.1
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
57
345
0.99
0.00
1.1
1.1
mg/l
348.1
332.8
0.18
46
314
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
10
57
1.05
0.00
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
340
2040
1.00
0.00
1.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
26
158
0.99
0.00
1.0
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
61
366
1.00
0.00
1.1
1.1
mg/l
52.0
46.6
0.37
50
321
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
36
217
0.99
0.00
1.1
1.1
miu/ml
1427.5
1634.8
0.43
36
217
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
25
148
1.01
0.00
1.1
1.2
mg/l
206.2
0.8
0.48
19
110
(3041918) Cholesterol [Moles/volume] in Pleural fluid
25
148
1.01
0.00
1.2
1.2
mmol/l
1.6
1.3
1.04
18
83
(3020393) Adenovirus Ag [Presence] in Stool
8
50
0.96
0.00
1.1
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
6
40
0.90
0.00
7.5
10.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
5
31
0.97
0.00
1.0
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
7
43
0.98
0.00
2.0
2.4
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
7
45
0.93
0.00
1.1
1.1
u/l
6100.0
294.2
—
7
38
(3009220) Epithelial cells.squamous [#/volume] in Urine sediment
0
5
0.00
0.00
0.0
1.2
—
1.8
—
0
5
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
7
45
0.93
0.00
1.0
1.2
—
—
—
0
0
(3028468) Fragments [Presence] in Blood by Light microscopy
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_PROSTATE_EXALLC – Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)
GWS hits: 116
This endpoint is excluded (different definition than used in FinnGen).